PURPLE INNOVATION, INC., 10-Q filed on 5/6/2025
Quarterly Report
v3.25.1
Cover - shares
 3 Months Ended
Mar. 31, 2025
May 02, 2025
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2025  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name PURPLE INNOVATION, INC.  
Entity Central Index Key 0001643953  
Entity File Number 001-37523  
Entity Tax Identification Number 47-4078206  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 4100 NORTH CHAPEL RIDGE ROAD  
Entity Address, Address Line Two SUITE 200  
Entity Address, City or Town LEHI  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84043  
Entity Phone Fax Numbers [Line Items]    
City Area Code (801)  
Local Phone Number 756-2600  
Class A Common Stock, par value $0.0001 per share    
Entity Listings [Line Items]    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share  
Trading Symbol PRPL  
Security Exchange Name NASDAQ  
Preferred Stock Purchase Rights    
Entity Listings [Line Items]    
Title of 12(b) Security Preferred Stock Purchase Rights  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
Class A Common Stock    
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   108,221,494
Class B Common Stock    
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   164,982
v3.25.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 21,627 $ 29,011
Accounts receivable, net 24,388 33,057
Inventories 60,177 56,863
Prepaid expenses 5,582 6,023
Other current assets 1,627 1,414
Total current assets 113,401 126,368
Property and equipment, net 90,433 93,874
Operating lease right-of-use assets 77,817 75,516
Intangible assets, net 8,215 8,890
Other long-term assets 3,906 3,197
Total assets 293,772 307,845
Current liabilities:    
Accounts payable 32,356 40,639
Accrued compensation 7,445 9,415
Customer prepayments 3,726 6,411
Accrued rebates and allowances 6,159 10,013
Accrued warranty liabilities – current portion 7,351 6,114
Operating lease obligations – current portion 15,904 15,661
Other current liabilities 10,672 12,750
Total current liabilities 83,613 101,003
Related party debt 72,737 55,394
Accrued warranty liabilities, net of current portion 24,367 26,091
Operating lease obligations, net of current portion 88,281 87,072
Warrant liabilities 21,414 16,067
Other long-term liabilities 2,030 2,009
Total liabilities 292,442 287,636
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Additional paid-in capital 594,332 594,053
Accumulated deficit (593,003) (573,866)
Total stockholders’ equity attributable to Purple Innovation, Inc. 1,340 20,198
Noncontrolling interest (10) 11
Total stockholders’ equity 1,330 20,209
Total liabilities and stockholders’ equity 293,772 307,845
Class A Common Stock    
Stockholders’ equity:    
Common stock; value 11 11
Class B Common Stock    
Stockholders’ equity:    
Common stock; value
v3.25.1
Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) - $ / shares
shares in Thousands
Mar. 31, 2025
Dec. 31, 2024
Class A Common Stock    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 210,000 210,000
Common stock, shares issued 107,955 107,545
Common stock, shares outstanding 107,955 107,545
Class B Common Stock    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 90,000 90,000
Common stock, shares issued 165 165
Common stock, shares outstanding 165 165
v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues, net $ 104,171 $ 120,033
Cost of revenues:    
Total cost of revenues 63,125 78,313
Gross profit 41,046 41,720
Operating expenses:    
Marketing and sales 36,626 41,462
General and administrative 14,487 19,728
Research and development 2,452 3,666
Restructuring, impairment and other related charges 1,960
Total operating expenses 55,525 64,856
Operating loss (14,479) (23,136)
Other income (expense):    
Interest expense (4,764) (4,474)
Other income, net 69 4,394
Gain (loss) on extinguishment of debt (3,394)
Change in fair value – warrant liabilities 49 (23,599)
Total other income (expense), net (4,646) (27,073)
Net loss before income taxes (19,125) (50,209)
Income tax expense (41) (59)
Net loss (19,166) (50,268)
Net loss attributable to noncontrolling interest (29) (51)
Net loss attributable to Purple Innovation, Inc. $ (19,137) $ (50,217)
Net loss per share:    
Basic (in Dollars per share) $ (0.18) $ (0.47)
Diluted (in Dollars per share) $ (0.18) $ (0.47)
Weighted average common shares outstanding:    
Basic (in Shares) 107,596,000 106,022,000
Diluted (in Shares) 107,596,000 106,022,000
Cost of revenues    
Cost of revenues:    
Total cost of revenues $ 62,207 $ 78,313
Restructuring charges    
Cost of revenues:    
Total cost of revenues $ 918
v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Total Stockholders’ Equity
Noncontrolling Interest
Total
Balance at Dec. 31, 2023 $ 11 $ 591,380 $ (475,969) $ 115,422 $ 185 $ 115,607
Balance (in Shares) at Dec. 31, 2023 105,507 205          
Net loss (50,217) (50,217) (51) (50,268)
Stock-based compensation 492 492 492
Issuance of stock for Intellibed acquisition
Issuance of stock for Intellibed acquisition (in Shares) 1,500          
Issuance of stock under equity compensation plans (115) (115) (115)
Issuance of stock under equity compensation plans (in Shares) 473          
Impact of transactions affecting NCI (33) (33) 33
Balance at Mar. 31, 2024 $ 11 591,724 (526,186) 65,549 167 65,716
Balance (in Shares) at Mar. 31, 2024 107,480 205          
Balance at Dec. 31, 2024 $ 11 594,053 (573,866) 20,198 11 20,209
Balance (in Shares) at Dec. 31, 2024 107,545 165          
Net loss (19,137) (19,137) (29) (19,166)
Stock-based compensation 368 368 368
Issuance of stock under equity compensation plans   (81) (81) (81)
Issuance of stock under equity compensation plans (in Shares) 410          
Impact of transactions affecting NCI     (8) (8) 8
Balance at Mar. 31, 2025 $ 11 $ 594,332 $ (593,003) $ 1,340 $ (10) $ 1,330
Balance (in Shares) at Mar. 31, 2025 107,955 165          
v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (19,166) $ (50,268)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,050 6,382
Non-cash interest 2,120 1,563
Paid-in-kind interest 2,789 1,850
Non-cash restructuring, impairment and other related charges 635
Loss on extinguishment of debt 3,394
Loss on disposal of property and equipment 88 112
Change in fair value – warrant liabilities (49) 23,599
Stock-based compensation 368 492
Changes in operating assets and liabilities:    
Accounts receivable 8,669 10,060
Inventories (3,314) (5,150)
Prepaid expenses and other assets 2,229 66
Operating leases, net (848) (209)
Accounts payable (9,701) (7,043)
Accrued compensation (1,970) 4,724
Customer prepayments (2,685) (1,724)
Accrued rebates and allowances (3,854) (4,717)
Accrued warranty liabilities (487) 368
Other accrued liabilities (2,944) (313)
Net cash used in operating activities (23,070) (16,814)
Cash flows from investing activities:    
Sale of property and equipment 258
Purchase of property and equipment (2,241) (3,038)
Investment in intangible assets (161) (62)
Net cash used in investing activities (2,144) (3,100)
Cash flows from financing activities:    
Proceeds from related party loan 19,000 61,000
Payments on term loan (25,000)
Payments on revolving line of credit (5,000)
Payments for debt issuance costs (1,170) (3,466)
Net cash provided by financing activities 17,830 27,534
Net increase (decrease) in cash and cash equivalents (7,384) 7,620
Cash and cash equivalents, beginning of the year 29,011 26,857
Cash and cash equivalents, end of the period 21,627 34,477
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest, net of amounts capitalized 39 410
Cash paid during the period for income taxes 28 46
Supplemental schedule of non-cash investing and financing activities:    
Property and equipment included in accounts payable 459 392
Warrants issued 5,396 19,571
Amendment fee added to principal of loan $ 978
v3.25.1
Organization
 3 Months Ended
Mar. 31, 2025
Organization [Abstract]  
Organization

1. Organization

 

The mission of Purple Innovation, Inc. (the “Company” or “Purple Inc.”) is to deliver the greatest sleep ever invented.

 

The Company, collectively with its subsidiary Purple Innovation, LLC (“Purple LLC”) is an omni-channel Company that began as a digitally-native vertical brand founded on comfort product innovation with premium offerings, and have since expanded into brick & mortar stores as a true omni-channel brand. The Company offers a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions, bases, sheets and other products. The Company markets and sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

 

The Company was incorporated in Delaware on May 19, 2015, as a special purpose acquisition company under the name of Global Partnership Acquisition Corp (“GPAC”). On February 2, 2018, the Company consummated a transaction structured similar to a reverse recapitalization (the “Business Combination”) pursuant to which the Company acquired a portion of the equity of Purple LLC. At the closing of the Business Combination (the “Closing”), the Company became the sole managing member of Purple LLC, and GPAC was renamed Purple Innovation, Inc.

 

As the sole managing member of Purple LLC, Purple Inc. through its officers and directors is responsible for all operational and administrative decision making and control of the day-to-day business affairs of Purple LLC without the approval of any other member.
v3.25.1
Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the accounts of Purple Inc., its controlled subsidiary Purple LLC, and Purple LLC’s wholly owned subsidiary Advanced Comfort Technologies, Inc., dba Intellibed (“Intellibed”). All intercompany balances and transactions have been eliminated in consolidation. As of March 31, 2025, Purple Inc. held 99.85% of the common units of Purple LLC and Purple LLC Class B Unit holders held 0.15% of the common units in Purple LLC.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The unaudited condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments (all of which were considered of normal recurring nature) considered necessary to present fairly the Company’s financial results. The results of the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025 or for any other interim period or other future year.

 

Liquidity

 

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. In connection with our preparation of our unaudited condensed consolidated financial statements for the three months ended March 31, 2025, the company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to its ability to continue as a going concern within one year after the date of the issuance of such financial statements. The Company had cash and cash equivalents of approximately $21.6 million and an accumulated deficit of $593.0 million at March 31, 2025, a net loss of $19.1 million and net cash used in operating and investing activities of $25.2 million for the three months ended March 31, 2025. The Company entered into the 2025 Amendment and the Second 2025 Amendment, pursuant to which it received an aggregate of $39.0 million in additional term loan proceeds.

 

The Company has also taken a number of other actions to increase cash flow. In August 2024, the Company implemented the Restructuring Plan to consolidate manufacturing operations to create efficiencies and cost savings. The Company has realized and plans to continue to realize direct material cost savings through supply chain initiatives and supplier diversification efforts. The Company has taken additional cost-saving initiatives in the first quarter of 2025 to maintain liquidity to support its operations and strategies. Additionally, the Company entered into an agreement with Mattress Firm, Inc. (“Mattress Firm”), a business unit of Somnigroup International, Inc. (“SGI”) to expand its inventory of the Company’s products across SGI’s national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots (see Note 21 — Subsequent Events).

 

Accordingly, the Company concluded that it will have sufficient liquidity to fund its operations for at least one year from the date of this Quarterly Report on Form 10-Q.

 

Although the Company currently expects its sources of capital to be sufficient to meet its near-term liquidity needs, there can be no assurance that such sources will be sufficient to satisfy its liquidity requirements in the future. If the Company cannot generate or obtain needed funds, it might be forced to make substantial reductions in its operating and capital expenses or pursue restructuring plans, which could adversely affect its business operations and ability to execute its current business strategy.

Variable Interest Entities

 

Purple LLC is a variable interest entity. The Company determined that it is the primary beneficiary of Purple LLC as it is the sole managing member and has the power to direct the activities most significant to Purple LLC’s economic performance as well as the obligation to absorb losses and receive benefits that are potentially significant. At March 31, 2025, Purple Inc. had a 99.85% economic interest in Purple LLC and consolidated 100% of Purple LLC’s assets, liabilities and results of operations in the Company’s unaudited condensed consolidated financial statements contained herein. The holders of Class B Units of Purple LLC (“Class B Units”) held 0.15% of the economic interest in Purple LLC as of March 31, 2025. For further discussion see Note 15 — Stockholders’ Equity.

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to establish accounting policies and to make estimates and judgments that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The Company regularly makes estimates and assumptions including, but not limited to, estimates that affect revenue recognition, accounts receivable and the allowance for credit losses, valuation of inventories, sales returns, warranty returns, impairment reviews of long-lived assets and definite-lived intangible assets, warrant liabilities, stock based compensation, the recognition and measurement of loss contingencies, the recognition and measurement of restructuring and related charges, estimates of current and deferred income taxes, deferred income tax valuation allowances, and amounts associated with the Company’s tax receivable agreement with InnoHold, LLC (“InnoHold”). Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. Actual results could differ materially from those estimates.

 

Segment Information

 

The Company operates in one operating segment. This is consistent with the organizational structure and internal reporting evaluated regularly by the Company’s Chief Executive Officer who is our chief operating decision maker (“CODM”) when making operational decisions and allocating resources. For additional information regarding the Company’s segment reporting, refer to Note 20 – Segment Information and Concentrations.

  

Recent Accounting Pronouncements

 

Improvements to Income Tax Disclosures

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU amends existing income tax disclosure guidance, primarily requiring more detailed disclosures for income taxes paid and the effective tax rate reconciliation. This ASU is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption. The guidance was effective for the Company as of January 1, 2025 and the new disclosure requirements will be effective in the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2025. Other than the new disclosure requirements, this guidance is not expected to have an impact on the Company’s consolidated financial statements.

 

Expense Disaggregation Disclosures

 

In November 2024, the FASB issued ASU No. 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The prescribed cost and expense categories requiring disaggregated disclosures include purchases of inventory, employee compensation, depreciation and intangible asset amortization, along with certain other expense disclosures already required by GAAP that would need to be integrated within the new tabular disaggregated expense disclosures. Additionally, the amendments also require the disclosure of total selling expenses and an entity’s definition of those expenses. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the potential impact this update will have on its expense disclosures in the notes to the consolidated financial statements.
v3.25.1
Restructuring, Impairment and Other Related Charges
 3 Months Ended
Mar. 31, 2025
Restructuring, Impairment and Other Related Charges [Abstract]  
Restructuring, Impairment and Other Related Charges

3. Restructuring, Impairment and Other Related Charges

 

In August 2024, the Company initiated a restructuring plan to strategically realign the Company’s focus on the achievement of operational efficiencies that are expected to improve profitability and provide for reinvesting in technology and marketing initiatives (the “Restructuring Plan”). The Company’s Restructuring Plan includes the permanent closure of its Grantsville and Salt Lake City, Utah manufacturing facilities to consolidate mattress production in its Georgia plant, and a headcount reduction at the Company’s Utah headquarters to drive additional operating efficiencies. Closure of the two Utah manufacturing facilities will be completed by the end of the second quarter of 2025 while consolidation into the Georgia facility was finalized in December 2024. The reduction in workforce at the Utah headquarters was completed in August 2024.

The following table summarizes the restructuring, impairment and other related charges the Company recognized through the first quarter of 2025 in the unaudited condensed consolidated statement of operations (in thousands):

 

   Cost of
Revenues		   Operating
Expenses		   Restructuring,
Impairment
and Other
Related
Charges		   Total 
Cash charges:                
Employee-related costs  $241   $942   $3,269   $4,452 
Other costs   688    
—
    1,682    2,370 
Total cash charges   929    942    4,951    6,822 
Non-cash charges:                    
Accelerated depreciation   11,406    
—
    135    11,541 
Inventory write-downs   4,026    
—
    
—
    4,026 
Write-down of long-lived assets   
—
    
—
    5,880    5,880 
Impairment of assets   
—
    
—
    10,967    10,967 
Total non-cash charges   15,432    
—
    16,982    32,414 
Total restructuring, impairment and other related  charges  $16,361   $942   $21,933   $39,236 

 

Of the $39.2 million in costs described above, the Company recognized $2.9 million of restructuring, impairment and other related charges during the three months ended March 31, 2025.

 

Accelerated depreciation primarily represents $11.5 million of increased depreciation expense associated with shortening the useful lives of the production equipment at the two Utah manufacturing facilities that are being closed to reflect the remaining period these assets will remain in service.

 

The $5.9 million write-down of long-lived assets represents the write-down to salvage value of other property and equipment located at the two Utah manufacturing facilities that are being closed.

 

Impairment of assets included impairment charges of $2.5 million associated with entering into a sublease for the Salt Lake City, Utah manufacturing facility that is being closed and related impairment charges associated with certain leasehold improvements of the property. The fair values of the impaired assets were determined by the Company to be Level 3 under the fair value hierarchy (refer to Note 4— Fair Value Measurements for the definition of Level 3 inputs) and were estimated based on internal expertise related to current marketplace conditions and estimated future discounted cash flows. These assets were adjusted to their estimated fair values at the time of impairment. If estimated fair values subsequently decline, the carrying values of the assets will be adjusted accordingly.

 

Impairment of assets also included the write-off of an $8.5 million indefinite-lived intangible asset. Initiating the Restructuring Plan was determined to be a triggering event for potential impairment of this asset. As a result of the impairment assessment performed, the Company determined this indefinite-lived intangible asset was impaired and recorded an impairment charge to write off the entire $8.5 million balance.

 

The lease for the Company’s Grantsville, Utah manufacturing facility included a five-year renewal option that was reasonably certain of being exercised and included in the lease term when the Right of Use (“ROU”) asset and lease liability were originally measured. Because of the expected closure of this facility as part of the Restructuring Plan, the renewal option was no longer deemed reasonably certain of being exercised and a reassessment of the lease terms was completed. As a result, the original lease term was shortened and the Company recorded a $10.5 million reduction to the ROU asset and corresponding lease liability in the 2024 consolidated balance sheet, using the applicable discount rate at the effective date of the reassessment.

The following table summarizes activity for the three months ended March 31, 2025 associated with employee-related and other costs recorded pursuant to the Restructuring Plan, as presented in the indicated line item of the consolidated statement of operations, that will be settled in cash and are included in accounts payable or accrued compensation on the unaudited condensed consolidated balance sheets (in thousands):

 

Liability balance at December 31, 2024  $993 
Employee-related costs – restructuring charges   171 
Other costs – restructuring charges   1,154 
Cash paid   (1,832)
Liability balance at March 31, 2025  $486 

 

The following table summarizes the estimated restructuring and other related charges associated with the Restructuring Plan to be recognized in the future (in thousands):

 

   Cost of
Revenues		   Operating
Expenses		   Restructuring,
Impairment
and Other Related
Charges		   Total 
Cash charges  $
—
   $
—
   $1,604   $1,604 
Non-cash charges   1,401    
—
    
—
    1,401 
Total estimated charges to be recognized in future (a)  $1,401   $
—
   $1,604   $3,005 

 

(a) These charges include certain estimates that are provisional and include management judgments and assumptions that could change materially as the Company completes the execution of the Restructuring Plan. Actual results may differ from these estimates, and the completion of the plan could result in additional restructuring, impairment or other related charges not reflected above.
v3.25.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2025
Fair Value Measurements [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

 

The Company uses the fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:

 

Level 1—Quoted market prices in active markets for identical assets or liabilities;

 

Level 2—Significant other observable inputs (i.e., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable, such as interest rate and yield curves, and market-corroborated inputs); and

 

Level 3—Unobservable inputs in which there is little or no market data, which require the reporting unit to develop its own assumptions.

 

The classification of fair value measurements within the established three-level hierarchy is based upon the lowest level of input that is significant to the measurements. Financial instruments, although not recorded at fair value on a recurring basis include cash and cash equivalents, receivables, accounts payable and the Company’s debt obligations. The carrying amounts of cash and cash equivalents, receivables, accounts payable and accrued expenses approximate fair value because of the short-term nature of these accounts.

 

The estimated fair value of the Company’s debt arrangements is based on Level 2 and Level 3 inputs. Level 2 inputs include observable inputs such as market-based expectations for interest rates, credit risk, volatility, and the contractual terms of debt instruments. The unobservable Level 3 inputs are associated with the required rate of return for the security implied by the March 2025 issuance of debt bundled with warrants, which were valued using a Monte Carlo model. As of March 31, 2025, the estimated fair value of the Company’s debt arrangements was $72.6 million.

 

The unobservable significant inputs to the valuation model were as follows:

 

   March 31, 
   2025 
Debt term in years   1.75 
Risk free interest rate   3.93%
SOFR interest rate   4.37%
Discount rate   32.50%

 

The warrant liabilities (see Note 11 — Warrant Liabilities for more information) are Level 3 instruments and use internal models to estimate fair value using certain significant unobservable inputs which require determination of relevant inputs and assumptions. Accordingly, changes in these unobservable inputs may have a significant impact on fair value. Such inputs include risk free interest rate, expected average life, expected dividend yield, and expected volatility. These Level 3 liabilities generally decrease (increase) in value based upon an increase (decrease) in risk free interest rate and expected dividend yield. Conversely, the fair value of these Level 3 liabilities generally increase (decrease) in value if the expected average life or expected volatility were to increase (decrease).

The following table summarizes the Company’s total Level 3 liability activity for the three months ended March 31, 2025 (in thousands):

 

Fair value as of December 31, 2024  $16,067 
Initial measurement at time of issuance(1)   5,396 
Change in valuation inputs(2)   (49)
Fair value as of March 31, 2025  $21,414 

 

(1) The Company issued 6.2 million warrants on March 12, 2025. See Note 11 – Warrant Liabilities.
(2) Changes in valuation inputs are recognized as the change in fair value – warrant liabilities in the unaudited condensed consolidated statement of operations.
v3.25.1
Revenue from Contracts with Customers
 3 Months Ended
Mar. 31, 2025
Revenue from Contracts with Customers [Abstract]  
Revenue from Contracts with Customers

5. Revenue from Contracts with Customers

 

The Company markets and sells its products through direct-to-consumer e-commerce channels, Purple showrooms, retail brick-and-mortar wholesale partners, and third-party online retailers. Revenue is recognized when the Company satisfies its performance obligations under the contract which involves transferring the promised products to the customer, subject to shipping terms. 

 

Disaggregated Revenue

 

The Company classifies revenue as either direct-to-consumer (“DTC”) or wholesale revenue. DTC revenues include the e-commerce channel which sells directly to consumers who purchase online, through the contact center, and through online marketplaces and the showrooms channel that sells directly to consumers who purchase at a Purple showroom location. The wholesale channel includes all product sales to the Company’s retail brick and mortar and online wholesale partners where consumers make purchases at their retail locations or through their online channels.

 

The following tables present the Company’s revenue disaggregated by sales channel (in thousands):

 

   Three Months Ended
March 31,		 
Sales Category  2025   2024 
e-commerce  $45,397   $49,474 
Showrooms   17,986    16,741 
Wholesale   40,788    53,818 
Revenues, net  $104,171   $120,033 

 

Contract Balances

 

Payments for the sale of products through the direct-to-consumer e-commerce channel, Purple showrooms and our contact center are collected at point of sale in advance of shipping the products. The amounts received for unshipped products are recorded as customer prepayments. Customer prepayments totaled $3.7 million and $6.4 million at March 31, 2025 and December 31, 2024, respectively. During the three months ended March 31, 2025, the Company recognized all of the revenue that was deferred in customer prepayments at December 31, 2024.
v3.25.1
Inventories
 3 Months Ended
Mar. 31, 2025
Inventories [Abstract]  
Inventories

6. Inventories

 

Inventories consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Raw materials  $16,769   $20,193 
Work-in-process   5,624    6,602 
Finished goods   37,784    30,068 
Inventories  $60,177   $56,863 
v3.25.1
Property and Equipment, Net
 3 Months Ended
Mar. 31, 2025
Property and Equipment [Abstract]  
Property and Equipment, Net

7. Property and Equipment, Net

 

Property and equipment, net consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Equipment  $73,418   $70,900 
Equipment in progress   11,042    13,130 
Leasehold improvements   57,910    57,936 
Furniture and fixtures   31,579    32,699 
Office equipment   1,638    1,611 
Total property and equipment   175,587    176,276 
Accumulated depreciation   (85,154)   (82,402)
Property and equipment, net  $90,433   $93,874 

 

Equipment in progress reflects equipment, primarily related to mattress manufacturing, which is being constructed and was not in service at March 31, 2025 or December 31, 2024. Interest capitalized on borrowings during the active construction period of major capital projects totaled $0.2 million and $0.4 million during the three months ended March 31, 2025 and 2024, respectively. Depreciation expense was $4.2 million and $5.2 million during the three months ended March 31, 2025 and 2024, respectively. Included in depreciation expense for the three months ended March 31, 2025 was $0.2 million related to accelerated depreciation associated with the Restructuring Plan. See Note 3— Restructuring and Impairment Charges for further discussion.
v3.25.1
Leases
 3 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Leases

8. Leases

 

The Company leases its manufacturing and distribution facilities, corporate offices, Purple showrooms and certain equipment under non-cancelable operating leases with various expiration dates through 2036. The Company’s office and manufacturing leases provide for initial lease terms up to 16 years, while Purple showrooms have initial lease terms of up to 10 years. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at the Company’s discretion. Any lease renewal options are included in the lease term if exercise is reasonably certain at lease commencement. The Company also leases vehicles and other equipment under both operating and finance leases with initial lease terms of three to five years. The ROU asset for finance leases totaled $0.9 million and $1.0 million at March 31, 2025 and December 31, 2024, respectively.

 

The following table presents the Company’s lease costs (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Operating lease costs  $4,780   $4,786 
Variable lease costs   1,042    869 
Short-term lease costs   42    

—

 
Total lease costs  $5,864   $5,655 

The table below reconciles the undiscounted cash flows for each of the first five years and total remaining years to the operating lease liabilities recorded on the unaudited condensed consolidated balance sheet at March 31, 2025 (in thousands):

 

2025 (excluding the three months ended March 31, 2025)(a)  $15,546 
2026   21,982 
2027   19,526 
2028   19,345 
2029   16,635 
Thereafter   34,038 
Total operating lease payments   127,072 
Less – lease payments representing interest   (22,887)
Present value of operating lease payments  $104,185 

 

(a) Amount consists of $16.4 million of undiscounted cash flows offset by $0.9 million of tenant improvement allowances which are expected to be fully utilized in fiscal 2025.

 

As of March 31, 2025 and December 31, 2024, the weighted-average remaining term of operating leases was 6.6 years and 6.8 years, respectively, and the weighted-average discount rate of operating leases was 6.24% and 6.09%, respectively.

 

The following table provides supplemental information related to the Company’s unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2025 and 2024 (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Cash paid for amounts included in present value of operating lease liabilities (b)  $4,099   $3,689 
Right-of-use assets obtained in exchange for operating lease liabilities   7,192    
—
 

 

  (b) Operating cash flows paid for operating leases are included within the change in operating leases, net within the unaudited condensed consolidated statement of cash flows offset by non-cash ROU asset amortization and lease liability accretion.
v3.25.1
Other Current Liabilities
 3 Months Ended
Mar. 31, 2025
Other Current Liabilities [Abstract]  
Other Current Liabilities

9. Other Current Liabilities

 

Other current liabilities consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Accrued sales returns  $4,563   $6,515 
Accrued sales tax and use tax   1,821    2,994 
Insurance financing   2,119    1,328 
Asset retirement obligation   1,298    1,440 
Other   871    473 
Total other current liabilities  $10,672   $12,750 
v3.25.1
Debt
 3 Months Ended
Mar. 31, 2025
Debt [Abstract]  
Debt

10. Debt

 

Debt consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Related party loan  $93,446   $70,679 
Less: unamortized debt issuance costs   (20,709)   (15,285)
Total debt   72,737    55,394 
Current portion of debt and unamortized issuance costs   
—
    
—
 
Debt, net of current portion  $72,737   $55,394 

 

2024 Credit Agreement

 

On January 23, 2024, Purple LLC, Purple Inc. and Intellibed (collectively, the “Loan Parties”) entered into an amended and restated credit agreement (the “Amended and Restated Credit Agreement”), which amended and restated the then existing term loan agreement (“Term Loan Agreement”), with Coliseum Capital Partners (“CCP”) and other lenders (collectively, the “Lenders”) and Delaware Trust Company, as administrative agent. The Lenders agreed to assume the Loan Parties’ obligations under the Term Loan Agreement and refinance their existing obligations. A term loan in the amount of $61.0 million (the “Related Party Loan”) was funded by the Lenders that repaid in full the $25.0 million of term loans outstanding, repaid in full the $5.0 million of asset based lending loans outstanding, paid fees, premiums and expenses incurred in connection with this transaction, and provided net proceeds to the Company (after payments of outstanding debt, unpaid accrued interest and expenses) equal to approximately $27.0 million. Interest on the Related Party Loan is payable each month and the principal outstanding matures and is due on December 31, 2026. The Company has elected for interest to be capitalized and added to the principal amount of the loan. The Related Party Loan bears interest at a rate equal to (i) the secured overnight financing rate as administered by the Federal Reserve Bank of New York plus 0.10%, with a floor of 3.5% per annum, plus (ii) 8.25% per annum (or, if Purple LLC elects to pay interest in kind to reduce it cash obligations, 10.25% per annum). Any prepayments of principal on or after August 7, 2024 but before August 7, 2025 are subject to a prepayment penalty of 1.25%, and any prepayments of principal on or after August 7, 2025 are subject to a prepayment penalty of 2.50%. The Loan Parties may request an additional term loan from the Lenders in an aggregate amount not to exceed $19.0 million on terms requested by them to the extent agreed to by the Lenders at their discretion. The Amended and Restated Credit Agreement also removed restrictions and requirements typically associated with an asset-based loan. 

 

In connection with the Amended and Restated Credit Agreement, the Company issued 20.0 million warrants (the “2024 Warrants”) to the Lenders (see Note 11 – Warrant Liabilities) and incurred additional fees and expenses of $3.5 million that were recorded as debt issuance costs in the first quarter of 2024 and are being amortized over the life of the loan.

 

The Amended and Restated Credit Agreement granted a security interest to the Lenders in substantially all of the assets (subject to certain limited exceptions) of the Loan Parties to secure the Loan Parties’ loans and other obligations under the Amended and Restated Credit Agreement, including a security interest in the intellectual property owned by the Loan Parties.

 

The Loan Parties (other than Purple LLC) provided an unconditional guaranty of the payment of all obligations and liabilities of Purple LLC under the Amended and Restated Credit Agreement.

 

The Amended and Restated Credit Agreement also provides for standard indemnification of the Lenders and contains representations, warranties and certain covenants of the Loan Parties. While any amounts are outstanding under the Amended and Restated Credit Agreement, the Loan Parties are subject to a number of affirmative and negative covenants, including covenants regarding dispositions of property, investments, forming or acquiring subsidiaries, business combinations or acquisitions, incurrence of additional indebtedness and transactions with affiliates, among other customary covenants. The Loan Parties are also restricted from paying dividends or making other distributions or payments on their capital stock, subject to limited exceptions. As of March 31, 2025, the Company was in compliance with all covenants under the Amended and Restated Credit Agreement.

2025 Amendment

 

On March 12, 2025, the Loan Parties, entered into the First Amendment to the Amended and Restated Credit Agreement (the “2025 Amendment” and the Amended and Restated Credit Agreement as so amended, the “Amended A&R Credit Agreement”) with CCP and Blackwell Partners LLC – Series A (“Blackwell”) (collectively the “2025 Lenders”), which amends the Amended and Restated Credit Agreement. The 2025 Amendment, among other things, provides for an increase in the initial principal amount of the Related Party Loan by $19.0 million (the “First Incremental Loan”) from an initial Related Party Loan principal amount of $61.0 million to an initial aggregate principal amount of $80.0 million, pursuant to Section 2.18 of the Amended and Restated Credit Agreement, and allows the Loan Parties to request one or more additional term loans from the 2025 Lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended and Restated Credit Agreement). The First Incremental Loan will bear interest at the same rate as the Initial Loan (as defined in the Amended and Restated Credit Agreement), which may be paid in cash or in kind at the Company’s option.

 

The 2025 Amendment also provides that (i) the First Incremental Loan shall be senior in right of repayment to the Related Party Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the First Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (i) the Make-Whole Premium (as defined below) and (ii) 2.50% of the aggregate principal amount of the First Incremental Loan so prepaid, replaced or assigned. The “Make-Whole Premium” is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such First Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such First Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such First Incremental Loan on such prepayment date.

 

The 2025 Amendment requires prepayment from certain amounts of proceeds received by the Company related to asset dispositions, equity issuances, incurrence of indebtedness, and extraordinary receipts. Additionally, upon an event of default, the 2025 Lenders may declare all or any portion of the term loan then outstanding to be accelerated and due and payable, immediately, including the prepayment premium. The Company determined that these features qualify as a derivative and must be bifurcated from the debt, but such value is de minimis. The Company will reassess whether the derivative has more than a de minimis value at each reporting period.

 

The 2025 Amendment also includes contingent interest upon an event of default at a rate of 2%. Certain non-credit related factors qualify as a derivative and must be bifurcated from the debt, but such value is de minimis.

 

In addition, the Company also paid (i) an amendment fee equal to 2% of the outstanding principal and accrued and unpaid interest under the Related Party Loan held by the 2025 Lenders, paid in kind and (ii) a 2% work fee of the initial aggregate principal amount of the First Incremental Loan paid to the 2025 Lenders, deducted from the proceeds at closing. Total fees and expenses of $2.1 million were recorded as a debt discount upon issuance of the Incremental Loan and are being amortized over the life of the loan.

 

In connection with the 2025 Amendment, the Company issued to the 2025 Lenders, warrants (the “2025 Warrants”) to purchase 6.2 million shares of the Company’s Class A common stock at a price of $1.50 per share, subject to certain adjustments (see Note 11 – Warrant Liabilities). These 2025 Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035. The 2025 Warrants had a fair value of $5.4 million upon issuance and were recorded as a debt discount upon issuance of the Incremental Loan and is being amortized over the life of the loan.

 

The 2025 Amendment was evaluated and determined to be a modification of debt as the effective borrowing rate was not reduced, therefore the 2025 Lenders did not grant a concession, and the 2025 Amendment terms were not substantially different from the Amended and Restated Credit Agreement.

 

The Company has elected to have interest paid-in-kind and added to the principal amount of the loans. Interest expense under the Related Party Loan and First Incremental Loan for the three months ended March 31, 2025 and 2024 consisted of paid-in-kind interest of $2.8 million and $1.9 million, respectively and debt issuance cost amortization of $2.1 million and $1.5 million, respectively. The effective interest rate was 14.68% and 15.68% for the three months ended March 31, 2025 and 2024, respectively.
v3.25.1
Warrant Liabilities
 3 Months Ended
Mar. 31, 2025
Warrant Liabilities [Abstract]  
Warrant Liabilities

11. Warrant Liabilities

 

On January 23, 2024, in connection with the Amended and Restated Credit Agreement, the Company issued 20.0 million 2024 Warrants to the Lenders and on March 12, 2025, in connection with the 2025 Amendment, the Company issued 6.2 million 2025 Warrants to the 2025 Lenders (collectively, the “Warrants”). Each Warrant entitles the registered holder to purchase one share of the Company’s Class A common stock at a price of $1.50 per share, subject to adjustment. While the Warrants are exercisable, the Company may call the Warrants for redemption in whole and not in part at any time at a price of $0.01 per share of Class A common stock issuable upon exercise of the Warrants upon not less than 45 days’ prior written notice of redemption to each holder, provided that this redemption right is only available if the reported last sale price of the Class A common stock equals or exceeds $24.00 per share on each of 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the holders. The Warrants will expire on the 10-year anniversary of issuance, or earlier upon redemption. The holders do not have the rights or privileges of holders of Class A common stock or any voting rights until they exercise their Warrants. After the issuance of shares of Class A common stock upon exercise of the Warrants, each holder will be entitled to one vote for each share of Class A common stock held on all matters to be voted on by stockholders generally. A holder of the Warrants will not have the right to exercise its Warrants, to the extent that after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 49.9% of the shares of Class A common stock outstanding immediately after giving effect to such exercise. The Warrants contain a repurchase provision which, upon an occurrence of a fundamental transaction as defined in the warrant agreement, could give rise to an obligation of the Company to pay cash to the warrant holders. In addition, other provisions may lead to a reduction in the exercise price of the Warrants. The Company determined the fundamental transaction provisions require the Warrants to be accounted for as a liability at fair value on the date of the transaction, with changes in fair value recognized in earnings in the period of change. As a result, the liability for these Warrants was recorded at fair value on the date of issuance with the offset included in debt issuance costs. This liability is subsequently re-measured to fair value at each reporting date or exercise date with changes in the fair value included in earnings. 

 

The Company used a Monte Carlo Simulation model to determine the fair value of the liability associated with the Warrants. The model used key assumptions and inputs, such as exercise price, fair market value of common stock, risk free interest rate, warrant life, expected volatility and the probability of a warrant re-price event. The following are the assumptions used in calculating fair value of the Warrants:

 

   March 31,   December 31, 
   2025   2024 
Trading price of common stock on measurement date  $0.76   $0.78 
Exercise price  $1.50   $1.50 
Risk free interest rate   4.09 – 4.14%    4.45%
Warrant life in years   8.82 – 9.95    9.06 
Expected volatility   88.0%   88.0%
Expected dividend yield   —    
—
 
Probability of an event causing a warrant re-price   25.0%   25.0%

 

The Warrants had a fair value of $21.4 million as of March 31, 2025. The Company recognized a de minimis gain in its unaudited condensed consolidated statement of operations for the three months ended March 31, 2025 related to a net decrease in the fair value of the Warrants outstanding at the end of the period compared to the fair value of the Warrants at issuance date and warrants outstanding at the end of 2024. The Company recorded a loss of $23.6 million for the three months ended March 31, 2024 related to the increase in fair value of the 2024 Warrants outstanding at the end of the period compared to the fair value of the warrants at issuance date. 
v3.25.1
Other Long-Term Liabilities
 3 Months Ended
Mar. 31, 2025
Other Long-Term Liabilities [Abstract]  
Other Long-Term Liabilities

12. Other Long-Term Liabilities

 

Other long-term liabilities consist of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Asset retirement obligations  $1,113   $1,098 
Other   917    911 
Total other long-term liabilities  $2,030   $2,009 
v3.25.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2025
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

13. Commitments and Contingencies

 

Warranty Liabilities

 

The Company provides a limited warranty on most of the products it sells. The estimated warranty costs associated with products sold through DTC channels are expensed at the time of sale and included in cost of revenues. The estimated warranty return costs associated with products sold through the wholesale channel are recorded at the time of sale and included as an offset to net revenues. Estimates for warranty costs are based on the results of product testing, industry and historical trends and warranty claim rates incurred, and are adjusted for any current or expected trends as appropriate. Actual warranty claim costs could differ from these estimates. The Company regularly assesses and adjusts the estimate of accrued warranty claims by updating claims rates for actual trends and projected claim costs. The Company classifies estimated warranty costs expected to be paid beyond a year as a long-term liability. The Company has accrued $31.7 million and $32.2 million in estimated future warranty costs as of March 31, 2025 and December 31, 2024, respectively.

 

Chief Executive Officer Cash Bonus Award

 

On January 26, 2024, the Company’s board of directors (the “Board”) approved an amendment to the Chief Executive Officer’s employment agreement. Under the amendment, the Company agreed that, among other things, the Chief Executive Officer will be eligible to earn a cash payment of up to $5.0 million, less tax and other required withholdings, based on the volume weighted average price per share of the Company’s Class A common stock on NASDAQ during the period from March 16, 2026 through June 30, 2026 subject to his continued employment with the Company. The amount earned will be payable in quarterly installments commencing with the first payroll period following June 30, 2026. The Company determined the provisions surrounding the future bonus payment require it to be accounted for as a liability at fair value on the date of the transaction, with changes in fair value recognized in earnings in the period of change. The Company recorded a de minimis compensation expense reduction in its unaudited condensed consolidated statement of operations for the three months ended March 31, 2025 and $0.4 million in compensation expense for three months ended March 31, 2024, related to this future bonus payment.

 

Senior Leadership Team Special Recognition Bonus

 

On January 26, 2024, the Board unanimously approved a special recognition bonus payment to certain members of the Company’s senior leadership team. The bonus was awarded to incentivize retention and continued engagement with the Company during these challenging times in the bedding industry. Each participant is eligible to earn a special recognition bonus payment equal to 15 months of their regular salary. The special recognition bonus payment is paid as follows, subject to the employee’s continued employment with the Company: 10% was paid in August 2024, 20% was paid in February 2025, and the remaining 70% is to be paid in August 2025. Related to this bonus payment, the Company recorded a de minimis compensation expense for the three months ended March 31, 2025 and $0.6 million compensation expense for the three months ended March 31, 2024 in its unaudited condensed consolidated statement of operations.

 

Performance Cash Long-Term Incentive Award

 

On June 20, 2024, the Board unanimously approved a performance cash long-term incentive award to those employees eligible to participate in the Company’s Long-Term Incentive Plan. The incentive award payment is based on a performance goal of the volume weighted average price per share of the Company’s Class A common stock on NASDAQ on March 31, 2027. The Company determined the provisions surrounding the performance cash long-term incentive award require it to be accounted for as a liability at fair value at each reporting period, with changes in fair value recognized in earnings in the period of change. The Company recorded a de minimis amount of compensation expense in the unaudited consolidated statement of operations for the three months ended March 31, 2025 related to this future award payment.

 

Settlement of Insurance Claim

 

In January 2024, the Company received a $4.3 million payment for partial settlement of a previously filed business interruption claim which was recorded during the first quarter of 2024 as other income, net in the unaudited condensed consolidated statement of operations.

Rights of Securities Holders

 

On January 23, 2024, in connection with the issuance of the 2024 Warrants, the Company entered into an amended and restated registration rights agreement (the “Registration Rights Agreement”) with holders of the 2024 Warrants (the “2024 Holders”), providing for the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the 2024 Warrants, the shares issuable upon the exercise of the 2024 Warrants and Class A common stock held by the 2024 Holders as of such date (the “Registrable Securities”), subject to customary terms and conditions. The Registration Rights Agreement entitles the 2024 Holders to demand registration of the Registrable Securities and to piggyback on the registration of securities by the Company and other Company security holders. The Company will be responsible for the payment of the 2024 Holders’ expenses in connection with any offering or sale of Registrable Securities by the 2024 Holders, including underwriting discounts or selling commissions, placement agent or broker fees or similar discounts, commissions or fees relating to the sale of certain Registrable Securities. The Registration Rights Agreement provided further that the Company was required to prepare and file with the SEC a registration statement to register the resale of the Registrable Securities. The registration statement filed by the Company on March 21, 2024 registering the Registrable Securities became effective on June 4, 2024.

 

In connection with the issuance of the 2025 Warrants, on March 12, 2025, the Company entered into a Second Amended and Restated Registration Rights Agreement (the “2025 Registration Rights Agreement”) with CCP, Blackwell, and Coliseum Capital Co-Invest III, L.P., (the “2025 Holders”), providing for the registration under the Securities Act of the 2025 Warrants, the shares issuable upon the exercise of the 2025 Warrants, other warrants held by the 2025 Holders (and shares issuable upon exercise thereof) and the Class A common stock held by the 2025 Holders as of such date (the “2025 Registrable Securities”), subject to customary terms and conditions. The 2025 Registration Rights Agreement entitles the 2025 Holders to demand registration of the 2025 Registrable Securities and also to piggyback on the registration of Company securities by the Company and other Company securityholders. The Company will be responsible for the payment of the 2025 Holders’ expenses in connection with any offering or sale of the 2025 Registrable Securities by the 2025 Holders, including underwriting discounts or selling commissions, placement agent or broker fees or similar discounts, commissions or fees relating to the sale of certain 2025 Registrable Securities.

 

The 2025 Registration Rights Agreement provides that on or prior to May 30, 2025 if Form S-3 is not then available to the Company, the Company will be required to prepare and file with the SEC pursuant to Rule 415 of the Securities Act a registration statement to register the resale of the Registrable Securities.

 

NOL Rights Plan

 

On June 27, 2024, the Board approved the adoption of a limited-duration stockholder rights agreement (the “NOL Rights Plan”) with a stated expiration date of June 30, 2025. The Board approved the NOL Rights Plan to protect stockholder value by attempting to safeguard the Company’s ability to use its June 30, 2024 estimated $238 million of net operating losses (the “Current NOLs”) to reduce potential future federal income tax obligations from becoming substantially limited by future ownership changes in the Company’s common stock under Code Section 382. On October 15, 2024, at a special meeting of stockholders (the “Special Meeting”), the Company’s stockholders ratified the NOL Rights Plan. See Note 15 – Stockholders’ Equity – NOL Rights Plan for further discussion of the NOL Rights Plan. On May 6, 2025, the Board approved the early terminated the NOL Rights Plan, effective May 7, 2025.

 

NOL Protective Charter Amendment

 

To further safeguard the Company’s ability to use its Current NOLs, on July 27, 2024, the Board adopted, and recommended that the Company’s stockholders approve, an amendment to the Company’s Certificate of Incorporation (the “NOL Protective Charter Amendment”) that adds an additional layer of protection of the Current NOLs until June 30, 2025 by voiding certain transfers of common stock that could result in an ownership change under Code Section 382. At the Special Meeting, the Company’s stockholders approved the NOL Protective Charter Amendment. See Note 15 – Stockholders’ Equity – NOL Protective Charter Amendment for further discussion of the NOL Protective Charter Amendment.

Non-Income Related Taxes

 

The U.S. Supreme Court ruling in South Dakota v. Wayfair, Inc., No.17-494, reversed a longstanding precedent that remote sellers are not required to collect state and local sales taxes. The Company cannot predict the effect of these and other attempts to impose sales, income or other taxes on e-commerce. The Company currently collects and reports on sales tax in all states in which it does business. However, the application of existing, new or revised taxes on the Company’s business, in particular, sales taxes, value-added tax and similar taxes would likely increase the cost of doing business online and decrease the attractiveness of selling products over the internet. The application of these taxes on the Company’s business could also create significant increases in internal costs necessary to capture data and collect and remit taxes. There have been, and will continue to be, substantial ongoing costs associated with complying with the various indirect tax requirements in the numerous markets in which the Company conducts or will conduct business.

 

Legal Proceedings

 

On December 16, 2022, Purple’s founders filed a complaint against Purple Inc. in the Fourth Judicial District Court in the State of Utah. In that suit, the plaintiffs alleged that they each entered into employment agreements with Purple LLC in February 2018. The plaintiffs contended that certain corporate transactions reduced their “ownership interest and voting power in Purple” and that, as a result, they should have continued to be paid a salary when they retired from Purple LLC. The plaintiffs calculated that they were each owed “no less than $500,000” in unpaid salary. In October 2023, the Court granted Purple Inc.’s motion and ordered that the claims brought by the plaintiffs be dismissed in full, with prejudice. The Court entered a final judgment dismissing the case in January 2024. The plaintiffs have an appeal to the Utah Court of Appeals. After oral arguments, on April 3, 2025 Court of Appeals ordered that the case return to District Court for further fact finding. Purple Inc. has petitioned the Utah Supreme Court to hear the case and affirm dismissal in full. If a hearing is granted by the Utah Supreme Court, the parties would argue before the Utah Supreme Court in the second half of 2025. The Company maintains insurance to cover the costs of defending against claims of this nature and intends to continue to vigorously defend against these claims in the course of the plaintiffs’ appeal. 

 

On April 3, 2023, Purple’s founders filed a complaint against Purple LLC in the Delaware Court of Chancery. The complaint alleges that Purple LLC breached the limited liability company agreement of Purple LLC by failing to pay the full amount of tax distributions owed under the agreement. The plaintiffs seek damages of approximately $3.0 million in allegedly unpaid tax distributions as well as legal fees and expenses incurred in connection with the litigation. On June 13, 2023, Purple LLC filed an answer to the complaint denying the plaintiffs’ allegations, setting forth its affirmative defenses, and requesting dismissal of all claims and entry of judgment in Purple LLC’s favor. The outcome of the litigation cannot be predicted at this early stage in the proceedings. Purple LLC denies all allegations and intends to vigorously defend against these claims. 

 

On April 16, 2024, Purple’s founders, in their capacity as a former landlord of Purple LLC, brought a lawsuit against Purple LLC, as lessee, for amounts allegedly owed under a real estate lease which the parties terminated effective September 30, 2023. In the suit, the plaintiffs allege approximately $2.5 million in damages, based primarily on a dispute regarding whether Purple LLC left the premises in the condition required by the lease. The plaintiffs further claim approximately $0.8 million in holdover rent, as well as unspecified amounts in interest, late fees, liquidated damages, attorney fees and costs. Purple LLC denies all allegations and intends to vigorously defend against these claims.

 

On July 24, 2024, a former part-time employee filed a class action lawsuit against Purple LLC in California Superior Court in the County of Alameda alleging failure to pay all wages, failure to pay overtime pay rate, failure to provide all meal periods, and other employment-related causes of action. The suit seeks damages, interest, attorneys’ fees, costs and other relief on behalf of all non-exempt California employees of Purple LLC during the applicable statutory periods. On September 30, 2024, the plaintiffs filed an amended complaint adding a claim for penalties under California’s Private Attorneys General Act. Subsequent to this, Purple LLC and the plaintiffs agreed to mediate the claims and to stay formal discovery pending mediation, which is currently scheduled to take place on May 8, 2025. Purple LLC denies all allegations and intends to vigorously defend against these claims.

 

On February 10, 2025, a shareholder of the Company filed a class action lawsuit in the Court of Chancery of the State of Delaware against Purple Inc. and the individual members of the Board alleging that Section 29 of the NOL Rights Plan violates Delaware General Corporate Law Sections 102(b)(7) and 141(a). The suit seeks declaratory relief, attorneys’ fees, costs, and other relief on behalf of the class. The Company denies all allegations and intends to vigorously defend against these claims. 

On February 26, 2025, a consumer filed a class action lawsuit in the U.S. District Court, Eastern District of New York, against Purple LLC alleging website accessibility violations under the ADA and state law. The lawsuit seeks declaratory relief, class certification, attorneys’ fees, costs, and other relief on behalf of the class. Purple LLC denies all allegations and intends to vigorously defend against these claims. 

 

On April 15, 2025, a consumer filed a class action lawsuit in the U.S. District Court, District of Minnesota, against Purple LLC alleging website accessibility violations under the ADA and state law. The lawsuit seeks declaratory relief, class certification, attorneys’ fees, costs, and other relief on behalf of the class. Purple LLC denies all allegations and intends to vigorously defend against these claims. 

 

The Company and Purple LLC are from time to time involved in various other claims, legal proceedings and complaints arising in the ordinary course of business. The Company does not believe that adverse decisions in any such pending or threatened proceedings, or any amount that the Company might be required to pay by reason thereof, would have a material adverse effect on the financial condition or future results of the Company.
v3.25.1
Related Party Transactions
 3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions

14. Related Party Transactions

 

The Company has engaged in various transactions with entities or individuals which are considered related parties.

 

Coliseum Capital Management, LLC

 

Immediately following the Business Combination, Adam Gray was appointed to the Board. Mr. Gray is a manager of Coliseum Capital, LLC, which is the general partner of CCP and Coliseum Co-Invest Debt Fund, L.P. (“CDF”), and he is also a managing partner of CCM, which is the investment manager of Blackwell and also manages investment funds and accounts. Mr. Gray has voting and dispositive control over securities held by CCP, CDF and Blackwell. Lenders under the Amended and Restated Credit Agreement and 2025 Lenders under the 2025 Amendment included CCP and Blackwell. See Note 10— Debt—2024 Credit Agreement for further discussion. In April 2023, Adam Gray was appointed Chairman of the Board of the Company as part of an agreement to resolve litigation that had been brought by Coliseum against the Company.
v3.25.1
Stockholders’ Equity
 3 Months Ended
Mar. 31, 2025
Stockholders’ Equity [Abstract]  
Stockholders’ Equity

15. Stockholders’ Equity

 

Class A Common Stock

 

The Company has 210.0 million shares of Class A common stock authorized. Holders of the Company’s Class A common stock are entitled to one vote for each share held on all matters to be voted on by the stockholders. Holders of Class A common stock and holders of Class B common stock voting together as a single class have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders. At March 31, 2025, 108.0 million shares of Class A common stock were outstanding.

 

Class B Common Stock

 

The Company has 90.0 million shares of Class B common stock authorized. Holders of the Company’s Class B common stock will vote together as a single class with holders of the Company’s Class A common stock on all matters properly submitted to a vote of the stockholders. Shares of Class B common stock may be issued only to InnoHold, their respective successors and assigns, as well as any permitted transferees of InnoHold. A holder may transfer their shares of Class B common stock to any transferee (other than the Company) only if such holder also simultaneously transfers an equal number of such holder’s Class B Units to such transferee. The Class B common stock is not entitled to receive dividends, if declared by the Board, or to receive any portion of any such assets in respect of their shares upon liquidation, dissolution, distribution of assets or winding-up of the Company in excess of the par value of such stock. At March 31, 2025, 0.2 million shares of Class B common stock were outstanding.

Preferred Stock

 

The Company has 5.0 million shares of preferred stock authorized. The preferred stock may be issued from time to time in one or more series. The Board is expressly authorized to provide for the issuance of shares of the preferred stock in one or more series and to establish from time to time the number of shares to be included in each such series and to fix the voting rights, designations and other special rights or restrictions. On June 27, 2024, 0.3 million shares of the Company’s authorized shares of preferred stock were designated as Series C Junior Participating Preferred Stock, par value $0.0001 per share (“Series C Preferred Shares”). At March 31, 2025, there were no shares of preferred stock outstanding

 

NOL Rights Plan

 

On June 27, 2024, the Board adopted, and the Company entered into the NOL Rights Plan, which is designed to preserve approximately $238 million of the Company’s Current NOLs under Section 382 of the of the Internal Revenue Code of 1986, as amended (“Code Section 382”). At the Special Meeting, the Company’s stockholders ratified the NOL Rights Plan. The Company’s ability to use the Current NOLs to offset future taxable income may be significantly limited if the Company experiences an “ownership change” under Code Section 382, which occurs if one or more stockholders or groups of stockholders that is deemed to own at least 5% of the Company’s common stock increases their aggregate ownership by more than 50 percentage points over its lowest ownership percentage within a rolling three-year period. The NOL Rights Plan is intended to prevent an ownership change by acting as a deterrent to any Person (as such term is defined in the NOL Rights Plan) acquiring 4.9% or more of the outstanding common stock of the Company (or, in the case of a Grandfathered Person (as such term is defined in the NOL Rights Plan), an additional one-half of one percentage point of the outstanding common stock of the Company above their current ownership percentage). Any Person that acquires shares of the Company’s common Stock in violation of the limitations of the NOL Rights Plan is known as an “Acquiring Person.” For purposes of the NOL Rights Plan, “common stock” includes (i) the Class A common stock; (ii) the Class B common stock; and (iii) any interest that would be treated as “stock” of the Company pursuant to Treasury Regulation § 1.382-2T(f)(18). Notwithstanding the foregoing, the NOL Rights Plan allows for the exercise of currently outstanding conversion rights, exchange rights, warrants or options, or otherwise, without triggering the NOL Rights Plan. See Note 11 – Warrant Liabilities for further discussion of the Company’s outstanding warrants.

 

The NOL Rights Plan provided for the issuance of a dividend of one preferred share purchase right (a “Right”) for each share of common stock outstanding on July 26, 2024. Each Right entitles the holder to purchase from the Company one one-thousandth of a share of Series C Preferred Share for a purchase price of $2.75, subject to adjustment as provided in the NOL Rights Plan. Each Series C Preferred Share is designed to be the economic equivalent of one share of common stock.

 

Unless the Board determines to effect an exchange (as discussed below), each Right will become exercisable on the “Distribution Time,” which is the earlier to occur of (i) the tenth day following a public announcement, or the public disclosure of facts indicating, that a Person has become an Acquiring Person or (ii) the tenth business day (or such later date as may be determined by action of the Board prior to such time as any Person becomes an Acquiring Person) following the commencement of a tender offer or exchange offer the consummation of which would result in a Person becoming an Acquiring Person. After the Distribution Time, any Rights held by an Acquiring Person will be void and will not be exercisable. As a result, any Acquiring Person will be subject to significant dilution upon the occurrence of the Distribution Time. At any time after a Person becomes an Acquiring Person, but before such Acquiring Person holds more than 50% of the common stock, the Board, in its sole discretion, may instead extinguish the Rights by exchanging one share of Class A common stock for each Right, other than Rights held by the Acquiring Person.

 

The Rights will expire on the earliest to occur of (i) the close of business on June 30, 2025; (ii) the time at which the Rights are redeemed (as discussed below) or exchanged by the Company; (iii) the repeal of Code Section 382, if the Board determines that the NOL Rights Plan is no longer necessary for the preservation of the Current NOLs; or (v) the beginning of a taxable year of the Company to which the Board determines that no Current NOLs may be carried forward. At any time prior to the expiration of the NOL Rights Plan, the Company may redeem the Rights in whole, but not in part, at a price of $0.0001 per Right (subject to adjustment and payable in cash, Class A common stock or other consideration deemed appropriate by the Board). Immediately upon the action of the Board authorizing any redemption or at a later time as the Board may establish for the effectiveness of the redemption, the Rights will terminate and the only right of the holders of Rights will be to receive the redemption price.

 

The initial issuance of the Rights as a dividend had no tax, financial accounting or reporting impact. The fair value of the Rights is nominal, since the Rights were not exercisable when issued and no value is attributable to them. Additionally, the Rights do not meet the definition of a liability under GAAP and therefore are not being accounted for as a long-term obligation. Accordingly, unless the Rights become exercisable upon the occurrence of the Distribution Time as discussed above, the NOL Rights Plan and the Rights issued thereunder have no impact on the Company’s unaudited consolidated financial statements.

NOL Protective Charter Amendment

 

Concurrently with the adoption of NOL Rights Plan, on June 27, 2024, the Board adopted, and recommended that the Company’s stockholders approve at the Special Meeting, the NOL Protective Charter Amendment that adds an additional layer of protection of the Current NOLs until June 30, 2025 by voiding any transfer of common stock that results in any Person holding 4.9% or more of the outstanding common stock of the Company (or, in the case of a Person already holding more than 4.9% of the outstanding common stock of the Company as of the date of the NOL Protective Charter Amendment, one-half of one percentage point of the outstanding common stock of the Company above their current ownership percentage). At the Special Meeting, the Company’s stockholders approved the NOL Protective Charter Amendment.

 

Any acquisition of common stock in violation of the NOL Protective Charter Amendment will be void as of the date it is attempted. Upon the Company’s written demand, the purported acquiring stockholder must transfer the excess acquired common stock to the Company’s transfer agent (along with any dividends or other distributions paid with respect to such excess acquired common stock). The Company’s transfer agent is then required to sell such excess acquired common stock in an arm’s-length transaction (or series of transactions) that would not constitute a violation under the NOL Protective Charter Amendment. The net proceeds of the sale together with any other distributions with respect to such excess acquired common stock received by the Company’s transfer agent, after deduction of all costs incurred by the transfer agent, will be transferred first to the purported transferee in an amount, if any, up to the cost (or in the case of gift, inheritance or similar transfer, the fair market value of the excess securities on the date of the prohibited transfer) incurred by the purported transferee to acquire such excess securities, and the balance of the proceeds, if any, will be transferred to a charitable beneficiary. Further, the Company may hold any stockholder liable, to the fullest extent of the law, for any intentional violation of the NOL Protective Charter Amendment.

 

Warrants

 

In connection with the Amended and Restated Credit Agreement, the Company issued 20.0 million Warrants to the Lenders and on March 12, 2025 in connection with the 2025 Amendment, the Company issued 6.2 million 2025 Warrants to the 2025 Lenders. Each Warrant entitles the registered holder to purchase one share of the Company’s Class A common stock at a price of $1.50 per share, subject to adjustment. While the Warrants are exercisable, the Company may call the Warrants for redemption in whole and not in part at any time at a price of $0.01 per share of Class A common stock issuable upon exercise of the Warrants upon not less than 45 days’ prior written notice of redemption to each holder, provided that this redemption right is only available if the reported last sale price of the Class A common stock equals or exceeds $24.00 per share on each of 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the holders. A holder of the Warrants will not have the right to exercise its Warrants, to the extent that after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 49.9% of the shares of Class A common stock outstanding immediately after giving effect to such exercise.

 

Noncontrolling Interest

 

Noncontrolling interest (“NCI”) is the membership interest in Purple LLC held by holders other than the Company. At March 31, 2025 and December 31, 2024, the combined NCI percentage in Purple LLC was 0.15% and 0.15%, respectively. The Company has consolidated the financial position and results of operations of Purple LLC and reflected the proportionate interest held by all such Purple LLC Class B Unit holders as NCI.
v3.25.1
Income Taxes
 3 Months Ended
Mar. 31, 2025
Income Taxes [Abstract]  
Income Taxes

16. Income Taxes

 

The Company’s sole material asset is Purple LLC, which is treated as a partnership for U.S. federal income tax purposes and for purposes of certain state and local income taxes. Purple LLC’s net taxable income and any related tax credits are passed through to its members and are included in the members’ tax returns, even though such net taxable income or tax credits may not have actually been distributed. While the Company consolidates Purple LLC for financial reporting purposes, the Company will be taxed on its share of earnings of Purple LLC not attributed to the noncontrolling interest holders, which will continue to bear their share of income tax on its allocable earnings of Purple LLC. The income tax burden on the earnings taxed to the noncontrolling interest holders is not reported by the Company in its consolidated financial statements under GAAP.

 

The Company reported de minimis income tax expense on a pretax loss of $19.1 million for the three months ended March 31, 2025 as compared to various state taxes of $0.1 million on a pretax loss of $50.2 million for the three months ended March 31, 2024. This resulted in an effective tax rate of (0.21%) for the three months ended March 31, 2025 as compared to (0.12%) for the three months ended March 31, 2024. The Company’s effective tax rate for the three months ended March 31, 2025 differs from the statutory federal rate of 21% primarily due to the impact of the full valuation allowance recorded against the Company’s deferred tax assets at March 31, 2025.

In connection with the Business Combination, the Company entered into a tax receivable agreement with InnoHold, which provides for the payment by the Company to InnoHold of 80% of the net cash savings, if any, in U.S. federal, state and local income tax that the Company actually realizes (or is deemed to realize in certain circumstances) in periods after the Closing as a result of (i) any tax basis increases in the assets of Purple LLC resulting from the distribution to InnoHold of the cash consideration, (ii) the tax basis increases in the assets of Purple LLC resulting from the redemption by Purple LLC or the exchange by the Company, as applicable, of Class B Paired Securities or cash, as applicable, and (iii) imputed interest deemed to be paid by the Company as a result of, and additional tax basis arising from, payments it makes under the agreement.

 

As noncontrolling interest holders exercise their right to exchange or cause Purple LLC to redeem all or a portion of their Class B Units, a tax receivable agreement liability may be recorded based on 80% of the estimated future cash tax savings that the Company may realize as a result of increases in the basis of the assets of Purple LLC attributed to the Company as a result of such exchange or redemption. The amount of the increase in asset basis, the related estimated cash tax savings and the attendant liability to be recorded will depend on the price of the Company’s Class A common stock at the time of the relevant redemption or exchange.

 

The effects of uncertain tax positions are recognized in the consolidated financial statements if these positions meet a “more-likely-than-not” threshold. For those uncertain tax positions that are recognized in the consolidated financial statements, liabilities are established to reflect the portion of those positions it cannot conclude “more-likely-than-not” to be realized upon ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties would be included on the related tax liability line in the consolidated balance sheet. As of March 31, 2025, the Company had unrecognized tax benefits of $1.1 million.
v3.25.1
Net Loss Per Common Share
 3 Months Ended
Mar. 31, 2025
Net Loss Per Common Share [Abstract]  
Net Loss Per Common Share

17. Net Loss Per Common Share

 

Basic net income (loss) per common share is calculated by dividing net income (loss) attributable to common stockholders by the weighted average number of shares of Class A common stock outstanding during each period. Diluted net income (loss) per share reflects the weighted-average number of common shares outstanding during the period used in the basic net income (loss) computation plus the effect of common stock equivalents that are dilutive.

 

The following table sets forth the calculation of basic and diluted weighted average shares outstanding and net loss per share for the periods presented (in thousands, except per share amounts):

 

   Three Months Ended
March 31,		 
   2025   2024 
Numerator:        
Net loss attributable to Purple Innovation, Inc. – basic  $(19,137)  $(50,217)
Less – net loss attributed to noncontrolling interest   
—
    
—
 
Net loss attributable to Purple Innovation, Inc. – diluted  $(19,137)  $(50,217)
Denominator:          
Weighted average shares—basic   107,596    106,022 
Add – dilutive effect of Class B shares   
—
    
—
 
Weighted average shares—diluted   107,596    106,022 
Net loss per common share:          
Basic  $(0.18)  $(0.47)
Diluted  $(0.18)  $(0.47)

 

The Company excludes from the diluted net loss per common share computation potentially dilutive securities related to warrants, equity awards and convertible shares of Class B common stock when their exercise or performance vesting price is greater than the average market price of the Company’s common stock or they are otherwise anti-dilutive. Potentially dilutive securities that have been excluded from the calculation of diluted net loss per common share are as follows (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Warrants   26,230    20,000 
Restricted stock units   3,397    3,693 
Stock Options   529    863 
Class B Shares   165    205 
v3.25.1
Equity Compensation Plans
 3 Months Ended
Mar. 31, 2025
Equity Compensation Plans [Abstract]  
Equity Compensation Plans

18. Equity Compensation Plans

 

2017 Equity Incentive Plan

 

The Purple Innovation, Inc. 2017 Equity Incentive Plan (the “2017 Plan”) provides for grants of stock options, stock appreciation rights, restricted stock units and other stock-based awards. Directors, officers and other employees, as well as others performing consulting or advisory services for the Company and its subsidiaries, are eligible for grants under the 2017 Plan. As of March 31, 2025, an aggregate of 1.6 million shares remain available for issuance or use under the 2017 Plan.

 

Employee Stock Options

 

The following table summarizes the Company’s total stock option activity for the three months ended March 31, 2025:

 

   Options
(in thousands)		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Term in
Years		   Intrinsic
Value
(in thousands)		 
Options outstanding as of January 1, 2025   529   $7.17    2.2   $
—
 
Granted   
—
    
—
    
—
    
—
 
Exercised   
—
    
—
    
—
    
—
 
Forfeited   
—
    
—
    
—
    
—
 
Options outstanding as of March 31, 2025   529   $7.17    1.9   $
—
 

 

Outstanding and exercisable stock options as of March 31, 2025 are as follows:

 

      Options Outstanding     Options Exercisable  
Exercise Prices     Number of
Options
Outstanding
(in thousands)		     Weighted
Average
Remaining Life
(Years)		     Number of
Options
Exercisable
(in thousands)		     Weighted
Average
Remaining Life
(Years)		     Intrinsic
Value
(in thousands)		  
$ 6.82       500       2.0       333       2.0     $ —  
  13.12       29       0.1       29       0.1       —  

 

The following table summarizes the Company’s unvested stock option activity for the three months ended March 31, 2025:

 

    Options
(in thousands)		     Weighted
Average
Grant Date
Fair Value		  
Nonvested options as of January 1, 2025     167     $ 0.22  
Granted     —       —  
Vested     —       —  
Forfeited     —       —  
Nonvested options as of March 31, 2025     167     $ 0.22  

The estimated fair value of Company stock options is amortized over the options vesting period on a straight-line basis. Stock option expense was de minimis for the three months ended March 31, 2025 and 2024.

 

As of March 31, 2025, outstanding stock options had a de minimis amount of unrecognized stock compensation cost with a remaining recognition period of 0.1 years. There were no stock options that vested during the three months ended March 31, 2025.

 

Employee Restricted Stock Units

 

During the three months ended March 31, 2025, the Company granted 1.2 million restricted stock units under the 2017 Plan to certain members of the Company’s management team. The restricted stock awards had a weighted average grant date fair value of $0.66 per share. The estimated fair value of these awards is recognized on a straight-line basis over the vesting period.

 

The following table summarizes the Company’s restricted stock unit activity for the three months ended March 31, 2025:

 

   Number
Outstanding
(in thousands)		   Weighted
Average
Grant Date
Fair Value		 
Nonvested restricted stock units as of January 1, 2025   3,808   $1.91 
Granted   1,150    0.66 
Vested   (897)   2.16 
Forfeited   (664)   2.26 
Nonvested restricted stock units as of March 31, 2025   3,397   $1.35 

 

The Company recorded restricted stock unit expense of $0.4 million and $0.5 million during the three months ended March 31, 2025 and 2024, respectively.

 

For restricted stock units outstanding as of March 31, 2025, there were $2.8 million of total unrecognized stock compensation costs with a remaining recognition period of 1.8 years.

Aggregate Non-Cash Stock-Based Compensation

 

The Company has accounted for all stock-based compensation under the provisions of ASC 718 Compensation—Stock Compensation. This standard requires the Company to record a non-cash expense associated with the fair value of stock-based compensation over the requisite service period.

 

The following table summarizes the aggregate non-cash stock-based compensation recognized in the statement of operations for stock awards, employee stock options and employee restricted stock units (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Cost of revenues  $103   $87 
Marketing and sales   (176)   96 
General and administrative   363    241 
Research and development   78    68 
Total non-cash stock-based compensation  $368   $492 
v3.25.1
Employee Retirement Plan
 3 Months Ended
Mar. 31, 2025
Employee Retirement Plan [Abstract]  
Employee Retirement Plan

19. Employee Retirement Plan

 

In July 2018, the Company established a 401(k) plan that qualifies as a deferred compensation arrangement under Section 401 of the IRS Code. All eligible employees over the age of 18 and with 4 months’ service are eligible to participate in the plan. The plan provides for the Company to match employee contributions up to 5% of eligible earnings. Company contributions immediately vest. The Company’s matching contribution expense was $1.1 million and $1.1 million for the three months ended March 31, 2025 and 2024, respectively.
v3.25.1
Segment Information and Concentrations
 3 Months Ended
Mar. 31, 2025
Segment Information and Concentrations [Abstract]  
Segment Information and Concentrations

20. Segment Information and Concentrations

 

The Company designs and manufactures a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions, bases, sheets, and other products. The Company has one reportable segment that operates an omni-channel distribution strategy which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. The Company’s one segment markets and sells products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

 

The accounting policies for the Company’s one segment are the same as those described in Note 2 – Summary of Significant Accounting Policies. The CODM assesses performance for the segment and decides how to allocate resources based on consolidated net income or loss as reported in the consolidated statement of operations. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The Company does not have intra-entity sales or transfers.

 

The CODM uses consolidated net income (loss) to evaluate earnings generated from segment assets (return on assets) in deciding whether to reinvest profits into its single reportable segment or into other parts of the entity, such as for acquisitions. Consolidated net income (loss) is also used to monitor budget versus actual results. The monitoring of budgeted versus actual results are used in assessing the segment’s performance and in establishing management’s compensation.

The following table summarizes segment revenue, significant segment expenses, other segment items and segment profit or loss (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Revenues, net  $104,171    120,033 
Reductions (additions):          
Cost of revenues   62,207    78,313 
Cost of revenues – restructuring related charges   918    
—
 
Advertising expense   14,602    14,499 
Marketing sales expense   7,187    8,399 
Wholesale marketing and sales expense   4,323    6,164 
Showrooms marketing and sales expense   10,514    12,400 
General and administrative expense   14,487    19,728 
Research and development expense   2,452    3,666 
Restructuring, impairment and other related charges   1,960    
—
 
Other segment items, net (d)   4,646    27,073 
Income tax expense   41    59 
Net loss attributable to noncontrolling interest   (29)   (51)
Net reductions   123,308    170,250 
Segment net loss  $(19,137)  $(50,217)

 

(d) Other segment items, net include interest expense, other (income) expense, net, loss on extinguishment of debt, and change in fair value of warrant liabilities.

 

The Company classifies products into two major categories: sleep products and other. Sleep products include mattresses, platforms, adjustable bases, mattress protectors, pillows and sheets. Other products include cushions and various other products. In the three months ended March 31, 2025 and 2024 sales of other products accounted for less than 3.0% of net revenues.

 

The Company defines international revenues as sales to customers located outside of the United States. In the three months ended March 31, 2025 and 2024 international customers accounted for less than 1.0% of net revenues.

 

The Company had one individual customer that accounted for approximately 36.0% and 21.1% of accounts receivable at March 31, 2025 and 2024, respectively, and approximately 11.9% and 13.6% of net revenue during the three months ended March 31, 2025 and 2024, respectively.

 

The Company currently obtains materials and components used in production from outside sources. As a result, the Company is dependent upon suppliers that in some instances, are the sole source of supply. The Company is continuing efforts to dual-source key components. The failure of one or more of the Company’s suppliers to provide materials or components on a timely basis could significantly impact the results of operations. The Company believes that it can obtain these raw materials and components from other sources of supply in the ordinary course of business, although an unexpected loss of supply over a short period of time may not allow for the replacement of these sources in the ordinary course of business.

 

The Company maintains its cash balances in financial institutions based in the United States that are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000 for each financial institution per entity. At times, the Company’s cash balance deposited at financial institutions exceed the federally insured deposit limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to these deposits.
v3.25.1
Subsequent Events
 3 Months Ended
Mar. 31, 2025
Subsequent Events [Abstract]  
Subsequent Events

21. Subsequent Events

 

Second 2025 Amendment

 

On May 2, 2025, the Loan Parties entered into a Second Amendment to the Amended and Restated Credit Agreement (the “Second 2025 Amendment”) with the 2025 Lenders, which amends the Amended A&R Credit Agreement. The Second 2025 Amendment, among other things, provides for a commitment increase pursuant to Section 2.18 of the Amended A&R Credit Agreement in the initial principal amount of the senior secured term loan facility by $20.0 million (the “Second Incremental Loan”) from an aggregate principal amount of up to $80.0 million (the “Existing Loan”) to an initial aggregate principal amount of up to $100.0 million (the “Loan”) and allows the Loan Parties to request one or more additional term loans from the Lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended A&R Credit Agreement). The Second Incremental Loan will bear interest at the same rate as the Existing Loan, which may be paid in cash or in kind at the Company’s option. 

 

The Second 2025 Amendment also provides that (i) the Second Incremental Loan shall be senior in right of repayment to the initial $61.0 million loan under the Amended and Restated Credit Agreement and pari passu with the First Incremental Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the Second Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (a) the Make-Whole Premium (as defined below) and (b) 2.5% of the aggregate principal amount of the Second Incremental Loan so prepaid, replaced or assigned. The “Make-Whole Premium” is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such Second Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such Second Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the Second 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such Second Incremental Loan on such prepayment date.

 

In addition, the Company also paid (i) an amendment fee equal to 0.25% of the outstanding principal and accrued and unpaid interest under the Existing Loan held by the Lenders, paid in kind to the 2025 Lenders, (ii) a work fee equal to 0.1% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, (iii) a waiver fee, to induce the Required Lenders to waive certain preemptive and right of first refusal rights, equal to 0.15% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, and (iv) a commitment fee equal to $150,000, paid in cash to the Required Lenders.

 

In connection with the Second 2025 Amendment, the Company issued to the 2025 Lenders, warrants (the “2025 Additional Warrants”) to purchase 6.6 million shares of the Company’s Class A common stock at a price of $1.50 per share, subject to certain adjustments. These 2025 Additional Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035.

 

SGI Commercial Arrangements

 

On May 2, 2025, the Company entered into a Second Amendment to Master Retailer Agreement (the “MRA Amendment”) with Mattress Firm, a business unit of SGI, which provides that SGI, through its Mattress Firm stores, will expand its inventory of the Company’s products across its national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots. Also on May 2, 2025, the Company entered into an Amended and Restated Master Vendor Supply and Services Agreement (the “Sherwood Agreement” and together with the MRA Amendment the “SGI Agreements”) with Tempur Sherwood, LLC, a subsidiary of Tempur Sealy. The Sherwood Agreement provides that Tempur Sherwood, LLC will have the exclusive right to assemble certain product lines that the Company sells to Mattress Firm.

 

In connection with the SGI Agreements, the Company issued to SGI warrants to purchase 8.0 million shares of the Company’s Class A Stock at a strike price of $1.50 per share (the “SGI Warrants”). The SGI Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035.

 

Early Termination of the NOL Rights Plan and NOL Protective Charter Amendment

 

On May 6, 2025, the Board accelerated the expiration date of the NOL Rights Plan and the NOL Protective Charter Amendment to May 7, 2025. In conjunction with the termination of the NOL Rights Plan, the Company filed a Certificate of Elimination eliminating the Series C Junior Participating Preferred Stock, effective May 7, 2025.
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure    
Net Income (Loss) $ (19,137) $ (50,217)
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Accounting Policies, by Policy (Policies)
 3 Months Ended
Mar. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of Purple Inc., its controlled subsidiary Purple LLC, and Purple LLC’s wholly owned subsidiary Advanced Comfort Technologies, Inc., dba Intellibed (“Intellibed”). All intercompany balances and transactions have been eliminated in consolidation. As of March 31, 2025, Purple Inc. held 99.85% of the common units of Purple LLC and Purple LLC Class B Unit holders held 0.15% of the common units in Purple LLC.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The unaudited condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments (all of which were considered of normal recurring nature) considered necessary to present fairly the Company’s financial results. The results of the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025 or for any other interim period or other future year.
Liquidity

Liquidity

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. In connection with our preparation of our unaudited condensed consolidated financial statements for the three months ended March 31, 2025, the company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to its ability to continue as a going concern within one year after the date of the issuance of such financial statements. The Company had cash and cash equivalents of approximately $21.6 million and an accumulated deficit of $593.0 million at March 31, 2025, a net loss of $19.1 million and net cash used in operating and investing activities of $25.2 million for the three months ended March 31, 2025. The Company entered into the 2025 Amendment and the Second 2025 Amendment, pursuant to which it received an aggregate of $39.0 million in additional term loan proceeds.

The Company has also taken a number of other actions to increase cash flow. In August 2024, the Company implemented the Restructuring Plan to consolidate manufacturing operations to create efficiencies and cost savings. The Company has realized and plans to continue to realize direct material cost savings through supply chain initiatives and supplier diversification efforts. The Company has taken additional cost-saving initiatives in the first quarter of 2025 to maintain liquidity to support its operations and strategies. Additionally, the Company entered into an agreement with Mattress Firm, Inc. (“Mattress Firm”), a business unit of Somnigroup International, Inc. (“SGI”) to expand its inventory of the Company’s products across SGI’s national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots (see Note 21 — Subsequent Events).

Accordingly, the Company concluded that it will have sufficient liquidity to fund its operations for at least one year from the date of this Quarterly Report on Form 10-Q.

Although the Company currently expects its sources of capital to be sufficient to meet its near-term liquidity needs, there can be no assurance that such sources will be sufficient to satisfy its liquidity requirements in the future. If the Company cannot generate or obtain needed funds, it might be forced to make substantial reductions in its operating and capital expenses or pursue restructuring plans, which could adversely affect its business operations and ability to execute its current business strategy.
Variable Interest Entities

Variable Interest Entities

Purple LLC is a variable interest entity. The Company determined that it is the primary beneficiary of Purple LLC as it is the sole managing member and has the power to direct the activities most significant to Purple LLC’s economic performance as well as the obligation to absorb losses and receive benefits that are potentially significant. At March 31, 2025, Purple Inc. had a 99.85% economic interest in Purple LLC and consolidated 100% of Purple LLC’s assets, liabilities and results of operations in the Company’s unaudited condensed consolidated financial statements contained herein. The holders of Class B Units of Purple LLC (“Class B Units”) held 0.15% of the economic interest in Purple LLC as of March 31, 2025. For further discussion see Note 15 — Stockholders’ Equity.
Use of Estimates

Use of Estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to establish accounting policies and to make estimates and judgments that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The Company regularly makes estimates and assumptions including, but not limited to, estimates that affect revenue recognition, accounts receivable and the allowance for credit losses, valuation of inventories, sales returns, warranty returns, impairment reviews of long-lived assets and definite-lived intangible assets, warrant liabilities, stock based compensation, the recognition and measurement of loss contingencies, the recognition and measurement of restructuring and related charges, estimates of current and deferred income taxes, deferred income tax valuation allowances, and amounts associated with the Company’s tax receivable agreement with InnoHold, LLC (“InnoHold”). Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. Actual results could differ materially from those estimates.
Segment Information

Segment Information

The Company operates in one operating segment. This is consistent with the organizational structure and internal reporting evaluated regularly by the Company’s Chief Executive Officer who is our chief operating decision maker (“CODM”) when making operational decisions and allocating resources. For additional information regarding the Company’s segment reporting, refer to Note 20 – Segment Information and Concentrations.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU amends existing income tax disclosure guidance, primarily requiring more detailed disclosures for income taxes paid and the effective tax rate reconciliation. This ASU is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption. The guidance was effective for the Company as of January 1, 2025 and the new disclosure requirements will be effective in the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2025. Other than the new disclosure requirements, this guidance is not expected to have an impact on the Company’s consolidated financial statements.

Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU No. 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The prescribed cost and expense categories requiring disaggregated disclosures include purchases of inventory, employee compensation, depreciation and intangible asset amortization, along with certain other expense disclosures already required by GAAP that would need to be integrated within the new tabular disaggregated expense disclosures. Additionally, the amendments also require the disclosure of total selling expenses and an entity’s definition of those expenses. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the potential impact this update will have on its expense disclosures in the notes to the consolidated financial statements.
v3.25.1
Restructuring, Impairment and Other Related Charges (Tables)
 3 Months Ended
Mar. 31, 2025
Restructuring, Impairment and Other Related Charges [Abstract]  
Schedule of Restructuring, Impairment and Other Related Charges

The following table summarizes the restructuring, impairment and other related charges the Company recognized through the first quarter of 2025 in the unaudited condensed consolidated statement of operations (in thousands):

 

   Cost of
Revenues		   Operating
Expenses		   Restructuring,
Impairment
and Other
Related
Charges		   Total 
Cash charges:                
Employee-related costs  $241   $942   $3,269   $4,452 
Other costs   688    
—
    1,682    2,370 
Total cash charges   929    942    4,951    6,822 
Non-cash charges:                    
Accelerated depreciation   11,406    
—
    135    11,541 
Inventory write-downs   4,026    
—
    
—
    4,026 
Write-down of long-lived assets   
—
    
—
    5,880    5,880 
Impairment of assets   
—
    
—
    10,967    10,967 
Total non-cash charges   15,432    
—
    16,982    32,414 
Total restructuring, impairment and other related  charges  $16,361   $942   $21,933   $39,236 

The following table summarizes the estimated restructuring and other related charges associated with the Restructuring Plan to be recognized in the future (in thousands):

 

   Cost of
Revenues		   Operating
Expenses		   Restructuring,
Impairment
and Other Related
Charges		   Total 
Cash charges  $
—
   $
—
   $1,604   $1,604 
Non-cash charges   1,401    
—
    
—
    1,401 
Total estimated charges to be recognized in future (a)  $1,401   $
—
   $1,604   $3,005 

 

(a) These charges include certain estimates that are provisional and include management judgments and assumptions that could change materially as the Company completes the execution of the Restructuring Plan. Actual results may differ from these estimates, and the completion of the plan could result in additional restructuring, impairment or other related charges not reflected above.
Schedule of Accounts Payable or Accrued Compensation

The following table summarizes activity for the three months ended March 31, 2025 associated with employee-related and other costs recorded pursuant to the Restructuring Plan, as presented in the indicated line item of the consolidated statement of operations, that will be settled in cash and are included in accounts payable or accrued compensation on the unaudited condensed consolidated balance sheets (in thousands):

 

Liability balance at December 31, 2024  $993 
Employee-related costs – restructuring charges   171 
Other costs – restructuring charges   1,154 
Cash paid   (1,832)
Liability balance at March 31, 2025  $486 
v3.25.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2025
Fair Value Measurements [Abstract]  
Schedule of Unobservable Significant Inputs to the Valuation Model

The unobservable significant inputs to the valuation model were as follows:

 

   March 31, 
   2025 
Debt term in years   1.75 
Risk free interest rate   3.93%
SOFR interest rate   4.37%
Discount rate   32.50%
Schedule of the Company’s Total Level 3 Liability Activity

The following table summarizes the Company’s total Level 3 liability activity for the three months ended March 31, 2025 (in thousands):

 

Fair value as of December 31, 2024  $16,067 
Initial measurement at time of issuance(1)   5,396 
Change in valuation inputs(2)   (49)
Fair value as of March 31, 2025  $21,414 

 

(1) The Company issued 6.2 million warrants on March 12, 2025. See Note 11 – Warrant Liabilities.
(2) Changes in valuation inputs are recognized as the change in fair value – warrant liabilities in the unaudited condensed consolidated statement of operations.
v3.25.1
Revenue from Contracts with Customers (Tables)
 3 Months Ended
Mar. 31, 2025
Revenue from Contracts with Customers [Abstract]  
Schedule of Revenue Disaggregated by Sales Channel

The following tables present the Company’s revenue disaggregated by sales channel (in thousands):

 

   Three Months Ended
March 31,		 
Sales Category  2025   2024 
e-commerce  $45,397   $49,474 
Showrooms   17,986    16,741 
Wholesale   40,788    53,818 
Revenues, net  $104,171   $120,033 
v3.25.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2025
Inventories [Abstract]  
Schedule of Inventories

Inventories consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Raw materials  $16,769   $20,193 
Work-in-process   5,624    6,602 
Finished goods   37,784    30,068 
Inventories  $60,177   $56,863 
v3.25.1
Property and Equipment, Net (Tables)
 3 Months Ended
Mar. 31, 2025
Property and Equipment [Abstract]  
Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Equipment  $73,418   $70,900 
Equipment in progress   11,042    13,130 
Leasehold improvements   57,910    57,936 
Furniture and fixtures   31,579    32,699 
Office equipment   1,638    1,611 
Total property and equipment   175,587    176,276 
Accumulated depreciation   (85,154)   (82,402)
Property and equipment, net  $90,433   $93,874 
v3.25.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Schedule of Lease Costs

The following table presents the Company’s lease costs (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Operating lease costs  $4,780   $4,786 
Variable lease costs   1,042    869 
Short-term lease costs   42    

—

 
Total lease costs  $5,864   $5,655 
Schedule of Operating Lease Liabilities

The table below reconciles the undiscounted cash flows for each of the first five years and total remaining years to the operating lease liabilities recorded on the unaudited condensed consolidated balance sheet at March 31, 2025 (in thousands):

 

2025 (excluding the three months ended March 31, 2025)(a)  $15,546 
2026   21,982 
2027   19,526 
2028   19,345 
2029   16,635 
Thereafter   34,038 
Total operating lease payments   127,072 
Less – lease payments representing interest   (22,887)
Present value of operating lease payments  $104,185 

 

(a) Amount consists of $16.4 million of undiscounted cash flows offset by $0.9 million of tenant improvement allowances which are expected to be fully utilized in fiscal 2025.
Schedule of Supplemental Information Related to the Company’s Condensed Consolidated Statement of Cash Flows

The following table provides supplemental information related to the Company’s unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2025 and 2024 (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Cash paid for amounts included in present value of operating lease liabilities (b)  $4,099   $3,689 
Right-of-use assets obtained in exchange for operating lease liabilities   7,192    
—
 

 

  (b) Operating cash flows paid for operating leases are included within the change in operating leases, net within the unaudited condensed consolidated statement of cash flows offset by non-cash ROU asset amortization and lease liability accretion.
v3.25.1
Other Current Liabilities (Tables)
 3 Months Ended
Mar. 31, 2025
Other Current Liabilities [Abstract]  
Schedule of Other Current Liabilities

Other current liabilities consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Accrued sales returns  $4,563   $6,515 
Accrued sales tax and use tax   1,821    2,994 
Insurance financing   2,119    1,328 
Asset retirement obligation   1,298    1,440 
Other   871    473 
Total other current liabilities  $10,672   $12,750 
v3.25.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2025
Debt [Abstract]  
Schedule of Debt

Debt consisted of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Related party loan  $93,446   $70,679 
Less: unamortized debt issuance costs   (20,709)   (15,285)
Total debt   72,737    55,394 
Current portion of debt and unamortized issuance costs   
—
    
—
 
Debt, net of current portion  $72,737   $55,394 
v3.25.1
Warrant Liabilities (Tables)
 3 Months Ended
Mar. 31, 2025
Warrant Liabilities [Abstract]  
Schedule of Fair Value of the Warrants The following are the assumptions used in calculating fair value of the Warrants:
   March 31,   December 31, 
   2025   2024 
Trading price of common stock on measurement date  $0.76   $0.78 
Exercise price  $1.50   $1.50 
Risk free interest rate   4.09 – 4.14%    4.45%
Warrant life in years   8.82 – 9.95    9.06 
Expected volatility   88.0%   88.0%
Expected dividend yield   —    
—
 
Probability of an event causing a warrant re-price   25.0%   25.0%
v3.25.1
Other Long-Term Liabilities (Tables)
 3 Months Ended
Mar. 31, 2025
Other Long-Term Liabilities [Abstract]  
Schedule of Other Long-Term Liabilities

Other long-term liabilities consist of the following (in thousands):

 

   March 31,   December 31, 
   2025   2024 
Asset retirement obligations  $1,113   $1,098 
Other   917    911 
Total other long-term liabilities  $2,030   $2,009 
v3.25.1
Net Loss Per Common Share (Tables)
 3 Months Ended
Mar. 31, 2025
Net Loss Per Common Share [Abstract]  
Schedule of Basic and Diluted Weighted Average Shares Outstanding and Loss Per Share

The following table sets forth the calculation of basic and diluted weighted average shares outstanding and net loss per share for the periods presented (in thousands, except per share amounts):

 

   Three Months Ended
March 31,		 
   2025   2024 
Numerator:        
Net loss attributable to Purple Innovation, Inc. – basic  $(19,137)  $(50,217)
Less – net loss attributed to noncontrolling interest   
—
    
—
 
Net loss attributable to Purple Innovation, Inc. – diluted  $(19,137)  $(50,217)
Denominator:          
Weighted average shares—basic   107,596    106,022 
Add – dilutive effect of Class B shares   
—
    
—
 
Weighted average shares—diluted   107,596    106,022 
Net loss per common share:          
Basic  $(0.18)  $(0.47)
Diluted  $(0.18)  $(0.47)
Schedule of Diluted Net Loss Per Common Share Potentially dilutive securities that have been excluded from the calculation of diluted net loss per common share are as follows (in thousands):
   Three Months Ended
March 31,		 
   2025   2024 
Warrants   26,230    20,000 
Restricted stock units   3,397    3,693 
Stock Options   529    863 
Class B Shares   165    205 
v3.25.1
Equity Compensation Plans (Tables)
 3 Months Ended
Mar. 31, 2025
Equity Compensation Plans [Abstract]  
Schedule of Total Stock Option Activity

The following table summarizes the Company’s total stock option activity for the three months ended March 31, 2025:

 

   Options
(in thousands)		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Term in
Years		   Intrinsic
Value
(in thousands)		 
Options outstanding as of January 1, 2025   529   $7.17    2.2   $
—
 
Granted   
—
    
—
    
—
    
—
 
Exercised   
—
    
—
    
—
    
—
 
Forfeited   
—
    
—
    
—
    
—
 
Options outstanding as of March 31, 2025   529   $7.17    1.9   $
—
 
Schedule of Outstanding and Exercisable Stock Options

Outstanding and exercisable stock options as of March 31, 2025 are as follows:

 

      Options Outstanding     Options Exercisable  
Exercise Prices     Number of
Options
Outstanding
(in thousands)		     Weighted
Average
Remaining Life
(Years)		     Number of
Options
Exercisable
(in thousands)		     Weighted
Average
Remaining Life
(Years)		     Intrinsic
Value
(in thousands)		  
$ 6.82       500       2.0       333       2.0     $ —  
  13.12       29       0.1       29       0.1       —  
Schedule of Unvested Stock Option Activity

The following table summarizes the Company’s unvested stock option activity for the three months ended March 31, 2025:

 

    Options
(in thousands)		     Weighted
Average
Grant Date
Fair Value		  
Nonvested options as of January 1, 2025     167     $ 0.22  
Granted     —       —  
Vested     —       —  
Forfeited     —       —  
Nonvested options as of March 31, 2025     167     $ 0.22  
Schedule of Restricted Stock Unit Activity

The following table summarizes the Company’s restricted stock unit activity for the three months ended March 31, 2025:

 

   Number
Outstanding
(in thousands)		   Weighted
Average
Grant Date
Fair Value		 
Nonvested restricted stock units as of January 1, 2025   3,808   $1.91 
Granted   1,150    0.66 
Vested   (897)   2.16 
Forfeited   (664)   2.26 
Nonvested restricted stock units as of March 31, 2025   3,397   $1.35 
Schedule of Non-Cash Stock Compensation Recognized in the Statement of Operations

The following table summarizes the aggregate non-cash stock-based compensation recognized in the statement of operations for stock awards, employee stock options and employee restricted stock units (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Cost of revenues  $103   $87 
Marketing and sales   (176)   96 
General and administrative   363    241 
Research and development   78    68 
Total non-cash stock-based compensation  $368   $492 
v3.25.1
Segment Information and Concentrations (Tables)
 3 Months Ended
Mar. 31, 2025
Segment Information and Concentrations [Abstract]  
Schedule of Summarizes Segment Revenue, Significant Segment Expenses

The following table summarizes segment revenue, significant segment expenses, other segment items and segment profit or loss (in thousands):

 

   Three Months Ended
March 31,		 
   2025   2024 
Revenues, net  $104,171    120,033 
Reductions (additions):          
Cost of revenues   62,207    78,313 
Cost of revenues – restructuring related charges   918    
—
 
Advertising expense   14,602    14,499 
Marketing sales expense   7,187    8,399 
Wholesale marketing and sales expense   4,323    6,164 
Showrooms marketing and sales expense   10,514    12,400 
General and administrative expense   14,487    19,728 
Research and development expense   2,452    3,666 
Restructuring, impairment and other related charges   1,960    
—
 
Other segment items, net (d)   4,646    27,073 
Income tax expense   41    59 
Net loss attributable to noncontrolling interest   (29)   (51)
Net reductions   123,308    170,250 
Segment net loss  $(19,137)  $(50,217)

 

(d) Other segment items, net include interest expense, other (income) expense, net, loss on extinguishment of debt, and change in fair value of warrant liabilities.
v3.25.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Summary of Significant Accounting Policies [Line Items]      
Common units percentage 99.85%    
Cash and cash equivalents (in Dollars) $ 21,627   $ 29,011
Accumulated deficit (in Dollars) (593,003)   $ (573,866)
Net loss (in Dollars) (19,137) $ (50,217)  
Cash used in operating and investing activities (in Dollars) 25,200    
Additional ter, loan proceeds (in Dollars) $ 39,000    
Economic interest 99.85%    
Asset liabilities percentage 100.00%    
Operating segment 1    
Purple LLC [Member]      
Summary of Significant Accounting Policies [Line Items]      
Common units percentage 0.15%    
Economic interest 0.15%    
v3.25.1
Restructuring, Impairment and Other Related Charges (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Restructuring, Impairment and Other Related Charges [Line Items]    
Recognized restructuring, impairment and other related charges $ 2,900  
Accelerated depreciation 11,500  
Salvage value of property and equipment 5,900  
Impairment of assets 8,500  
Impairment charge 635
Reduction of ROU asset 10,500  
Leasehold Improvements [Member]    
Restructuring, Impairment and Other Related Charges [Line Items]    
Impairment of assets 2,500  
Indefinite-Lived Intangible Asset [Member]    
Restructuring, Impairment and Other Related Charges [Line Items]    
Impairment charge 8,500  
Total restructuring, impairment and other related charges [Member]    
Restructuring, Impairment and Other Related Charges [Line Items]    
Total restructuring, impairment and other related charges $ 39,236  
v3.25.1
Restructuring, Impairment and Other Related Charges - Schedule of Restructuring, Impairment and Other Related Charges (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash charges:    
Operating Expenses, Cash charges $ 55,525 $ 64,856
Non-cash charges:    
Cost of Revenues, Total restructuring, impairment and other related charges 1,960
Non-cash charges [Member]    
Non-cash charges:    
Cost of Revenues, Non-cash charges 15,432  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges 16,982  
Total, Non-cash charges 32,414  
Total restructuring, impairment and other related charges [Member]    
Non-cash charges:    
Cost of Revenues, Total restructuring, impairment and other related charges 16,361  
Operating Expenses, Total restructuring, impairment and other related charges 942  
Restructuring, Impairment and Other Related Charges, Total restructuring, impairment and other related charges 21,933  
Total, Total restructuring, impairment and other related charges 39,236  
Restructuring Plan [Member]    
Cash charges:    
Cost of Revenues, Cash charges  
Operating Expenses, Cash charges  
Restructuring, Impairment and Other Related Charges, Cash charges 1,604  
Total, Cash charges 1,604  
Non-cash charges:    
Cost of Revenues, Non-cash charges 1,401  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges  
Total, Non-cash charges 1,401  
Cost of Revenues, Total restructuring, impairment and other related charges [1] 1,401  
Operating Expenses, Total restructuring, impairment and other related charges [1]  
Restructuring, Impairment and Other Related Charges, Total restructuring, impairment and other related charges [1] 1,604  
Total, Total restructuring, impairment and other related charges [1] 3,005  
Employee-related costs [Member] | Cash charges [Member]    
Cash charges:    
Cost of Revenues, Cash charges 241  
Operating Expenses, Cash charges 942  
Restructuring, Impairment and Other Related Charges, Cash charges 3,269  
Total, Cash charges 4,452  
Other costs [Member] | Cash charges [Member]    
Cash charges:    
Cost of Revenues, Cash charges 688  
Operating Expenses, Cash charges  
Restructuring, Impairment and Other Related Charges, Cash charges 1,682  
Total, Cash charges 2,370  
Cash charges [Member]    
Cash charges:    
Cost of Revenues, Cash charges 929  
Operating Expenses, Cash charges 942  
Restructuring, Impairment and Other Related Charges, Cash charges 4,951  
Total, Cash charges 6,822  
Accelerated depreciation [Member] | Non-cash charges [Member]    
Non-cash charges:    
Cost of Revenues, Non-cash charges 11,406  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges 135  
Total, Non-cash charges 11,541  
Inventory write-downs [Member] | Non-cash charges [Member]    
Non-cash charges:    
Cost of Revenues, Non-cash charges 4,026  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges  
Total, Non-cash charges 4,026  
Write-down of long-lived assets [Member] | Non-cash charges [Member]    
Non-cash charges:    
Cost of Revenues, Non-cash charges  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges 5,880  
Total, Non-cash charges 5,880  
Impairment of assets [Member] | Non-cash charges [Member]    
Non-cash charges:    
Cost of Revenues, Non-cash charges  
Operating Expenses, Non-cash charges  
Restructuring, Impairment and Other Related Charges, Non-cash charges 10,967  
Total, Non-cash charges $ 10,967  
[1] These charges include certain estimates that are provisional and include management judgments and assumptions that could change materially as the Company completes the execution of the Restructuring Plan. Actual results may differ from these estimates, and the completion of the plan could result in additional restructuring, impairment or other related charges not reflected above.
v3.25.1
Restructuring, Impairment and Other Related Charges - Schedule of Accounts Payable or Accrued Compensation (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
Schedule of Accounts Payable or Accrued Compensation [Line Items]  
Balance at beginning $ 993
Cash paid (1,832)
Balance at ending 486
Employee-related costs – restructuring charges [Member]  
Schedule of Accounts Payable or Accrued Compensation [Line Items]  
Cost for restructuring 171
Other costs – restructuring charges [Member]  
Schedule of Accounts Payable or Accrued Compensation [Line Items]  
Cost for restructuring $ 1,154
v3.25.1
Fair Value Measurements (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 12, 2025
Fair Value Measurements [Line Items]    
Estimated fair value of debt arrangements $ 72.6  
Warrant [Member]    
Fair Value Measurements [Line Items]    
Warrant issued   6.2
v3.25.1
Fair Value Measurements - Schedule of Unobservable Significant Inputs to the Valuation Model (Details)
Mar. 31, 2025
Measurement Input, Expected Term [Member]  
Schedule of Unobservable Significant Inputs to the Valuation Model [Line Items]  
Debt Instrument, Measurement Input 1.75
Measurement Input, Risk Free Interest Rate [Member]  
Schedule of Unobservable Significant Inputs to the Valuation Model [Line Items]  
Debt Instrument, Measurement Input 3.93
SOFR interest rate [Member]  
Schedule of Unobservable Significant Inputs to the Valuation Model [Line Items]  
Debt Instrument, Measurement Input 4.37
Measurement Input, Discount Rate [Member]  
Schedule of Unobservable Significant Inputs to the Valuation Model [Line Items]  
Debt Instrument, Measurement Input 32.5
v3.25.1
Fair Value Measurements - Schedule of the Company’s Total Level 3 Liability Activity (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
Schedule of the Company’s Total Level 3 Liability Activity [Abstract]  
Fair value as of December 31, 2024 $ 16,067
Initial measurement at time of issuance 5,396 [1]
Change in valuation inputs (49) [2]
Fair value as of March 31, 2025 $ 21,414
[1] The Company issued 6.2 million warrants on March 12, 2025. See Note 11 – Warrant Liabilities.
[2] Changes in valuation inputs are recognized as the change in fair value – warrant liabilities in the unaudited condensed consolidated statement of operations.
v3.25.1
Revenue from Contracts with Customers (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Revenue from Contracts with Customers [Abstract]    
Customer prepayments $ 3,726 $ 6,411
v3.25.1
Revenue from Contracts with Customers - Schedule of Revenue Disaggregated by Sales Channel (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Revenue Disaggregated by Sales Channel [Line Items]    
Revenues, net $ 104,171 $ 120,033
Sales Category [Member] | e-commerce [Member]    
Schedule of Revenue Disaggregated by Sales Channel [Line Items]    
Revenues, net 45,397 49,474
Sales Category [Member] | Showrooms [Member]    
Schedule of Revenue Disaggregated by Sales Channel [Line Items]    
Revenues, net 17,986 16,741
Sales Category [Member] | Wholesale [Member]    
Schedule of Revenue Disaggregated by Sales Channel [Line Items]    
Revenues, net $ 40,788 $ 53,818
v3.25.1
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Schedule of Inventories [Abstract]    
Raw materials $ 16,769 $ 20,193
Work-in-process 5,624 6,602
Finished goods 37,784 30,068
Inventories $ 60,177 $ 56,863
v3.25.1
Property and Equipment, Net (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Property and Equipment [Abstract]      
Interest capitalized borrowings $ 0.2   $ 0.4
Depreciation expense 4.2 $ 5.2  
Accelerated depreciation $ 0.2    
v3.25.1
Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross $ 175,587 $ 176,276
Accumulated depreciation (85,154) (82,402)
Property and equipment, net 90,433 93,874
Equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 73,418 70,900
Equipment in progress [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 11,042 13,130
Leasehold improvements [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 57,910 57,936
Furniture and fixtures [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross 31,579 32,699
Office equipment [Member]    
Schedule of Property and Equipment [Line Items]    
Property and equipment, gross $ 1,638 $ 1,611
v3.25.1
Leases (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Leases [Line Items]    
Initial lease term 16 years  
Finance lease ROU asset (in Dollars) $ 0.9 $ 1.0
Remaining years 5 years  
Undiscounted cash flows offset (in Dollars) $ 16.4  
Tenant improvement allowances (in Dollars) $ 0.9  
Weighted-average remaining term of operating leases 6 years 7 months 6 days 6 years 9 months 18 days
Weighted-average discount rate percentage 6.24% 6.09%
Minimum [Member]    
Leases [Line Items]    
Operating and finance leases with initial lease terms 3 years  
Maximum [Member]    
Leases [Line Items]    
Operating and finance leases with initial lease terms 5 years  
Purple Showrooms [Member]    
Leases [Line Items]    
Initial lease term 10 years  
v3.25.1
Leases - Schedule of Lease Costs (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Lease Costs [Abstract]    
Operating lease costs $ 4,780 $ 4,786
Variable lease costs 1,042 869
Short-term lease costs 42
Total lease costs $ 5,864 $ 5,655
v3.25.1
Leases - Schedule of Operating Lease Liabilities (Details)
$ in Thousands
Mar. 31, 2025
USD ($)
Schedule of Operating Lease Liabilities [Abstract]  
2025 (excluding the three months ended March 31, 2025)(a) $ 15,546
2026 21,982
2027 19,526
2028 19,345
2029 16,635
Thereafter 34,038
Total operating lease payments 127,072
Less – lease payments representing interest (22,887)
Present value of operating lease payments $ 104,185
v3.25.1
Leases - Schedule of Supplemental Information Related to the Company’s Condensed Consolidated Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Supplemental Information Related to the Company’s Condensed Consolidated Statement of Cash Flows [Abstract]    
Cash paid for amounts included in present value of operating lease liabilities [1] $ 4,099 $ 3,689
Right-of-use assets obtained in exchange for operating lease liabilities $ 7,192
[1] Operating cash flows paid for operating leases are included within the change in operating leases, net within the unaudited condensed consolidated statement of cash flows offset by non-cash ROU asset amortization and lease liability accretion.
v3.25.1
Other Current Liabilities - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Schedule of Other Current Liabilities [Abstract]    
Accrued sales returns $ 4,563 $ 6,515
Accrued sales tax and use tax 1,821 2,994
Insurance financing 2,119 1,328
Asset retirement obligation 1,298 1,440
Other 871 473
Total other current liabilities $ 10,672 $ 12,750
v3.25.1
Debt (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 3 Months Ended
Mar. 12, 2025
Jan. 23, 2024
Feb. 17, 2023
Mar. 31, 2025
Mar. 31, 2024
Jan. 23, 2025
Aug. 07, 2024
Debt [Line Items]              
Net proceeds   $ 27,000          
Financing rate, percentage   3.50%          
Prepayment penalty rate             2.50%
Warrants issued (in Shares)           20.0  
Aggregate principal amount $ 80,000            
Aggregate principal amount 20,000            
Percentage of aggregate principal amount       2.50%      
Principal Amount Percentage       100.00%      
Percentage of contingent interest       2.00%      
Percentage of outstanding principal       2.00%      
Debt issuance fees and expenses     $ 2,100        
Warrants fair value       $ (49) $ 23,599    
Paid-in-kind interest       2,789 1,850    
Debt issuance cost amortization       $ 2,100 $ 1,500    
Term Loan Lenders Warrants [Member]              
Debt [Line Items]              
Warrants issued (in Shares)       6.2      
Warrant price (in Dollars per share)       $ 0.6979      
2025 Warrants [Member]              
Debt [Line Items]              
Warrants fair value       $ 5,400      
Federal Reserve Bank of New York [Member]              
Debt [Line Items]              
Financing rate, percentage   0.10%          
2025 Amendment [Member]              
Debt [Line Items]              
Percentage of effective interest rate       14.68% 15.68%    
Related Party Loan [Member]              
Debt [Line Items]              
Term loan   $ 61,000          
Term Loans [Member]              
Debt [Line Items]              
Outstanding balance   25,000          
Asset Based Lending Loans [Member]              
Debt [Line Items]              
Outstanding balance   $ 5,000          
Incremental Loan [Member]              
Debt [Line Items]              
Secured term loan 19,000            
Percentage of aggregate principal amount       2.00%      
Initial Loan [Member]              
Debt [Line Items]              
Aggregate principal amount $ 61,000            
2024 Credit Agreement [Member]              
Debt [Line Items]              
Prepayment penalty rate             1.25%
Aggregate amount             $ 19,000
Debt issuance costs         $ 3,500    
Purple LLC [Member]              
Debt [Line Items]              
Financing rate, percentage   8.25%          
Pay interest rate   10.25%          
Class A Common Stock [Member]              
Debt [Line Items]              
Warrant price per share (in Dollars per share)       $ 1.5      
Warrant price (in Dollars per share)       $ 0.6979      
v3.25.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Schedule of Debt [Abstract]    
Related party loan $ 93,446 $ 70,679
Less: unamortized debt issuance costs (20,709) (15,285)
Total debt 72,737 55,394
Current portion of debt and unamortized issuance costs
Debt, net of current portion $ 72,737 $ 55,394
v3.25.1
Warrant Liabilities (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Jan. 23, 2024
Mar. 31, 2025
Mar. 31, 2024
Mar. 12, 2025
Dec. 31, 2024
Warrant Liabilities [Line Items]          
Purchase of each warrants 1        
Warrants term 10 years        
Warrant fair value   $ (49) $ 23,599    
Warrant [Member]          
Warrant Liabilities [Line Items]          
Warrant issued 20,000,000 20,000,000      
Warrant [Member]          
Warrant Liabilities [Line Items]          
Warrant issued       6,200,000  
Warrant fair value   $ 21,400      
Sponsor Warrants [Member]          
Warrant Liabilities [Line Items]          
Recognized gain (loss)   $ 23,600      
Class A Common Stock [Member]          
Warrant Liabilities [Line Items]          
Per share $ 0.01 $ 0.0001     $ 0.0001
Outstanding shares percentage 49.90%        
Class A Common Stock [Member] | Warrant [Member]          
Warrant Liabilities [Line Items]          
Per share   $ 24      
Class A Common Stock [Member] | Sponsor Warrants [Member]          
Warrant Liabilities [Line Items]          
Per share $ 1.5        
Redemption right last sales price $ 24        
v3.25.1
Warrant Liabilities - Schedule of Fair Value of the Warrants (Details)
Mar. 31, 2025
Dec. 31, 2024
Trading price of common stock on measurement date [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 0.76 0.78
Exercise price [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 1.5 1.5
Risk free interest rate [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants   4.45
Risk free interest rate [Member] | Minimum [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 4.09  
Risk free interest rate [Member] | Maximum [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 4.14  
Warrant life in years [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants   9.06
Warrant life in years [Member] | Minimum [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 8.82  
Warrant life in years [Member] | Maximum [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 9.95  
Expected volatility [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 88 88
Expected dividend yield [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants  
Probability of an event causing a warrant re-price [Member]    
Schedule of Fair Value of the Warrants [Line Items]    
Fair Value of Warrants 25 25
v3.25.1
Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Schedule of Other Long-Term Liabilities [Abstract]    
Asset retirement obligations $ 1,113 $ 1,098
Other 917 911
Total other long-term liabilities $ 2,030 $ 2,009
v3.25.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
 3 Months Ended
Aug. 31, 2025
Aug. 31, 2024
Jun. 30, 2024
Apr. 16, 2024
Jan. 26, 2024
Apr. 03, 2023
Dec. 16, 2022
Mar. 31, 2025
Mar. 31, 2024
Jan. 31, 2024
Commitments and Contingencies [Line Items]                    
Accrued estimated future warrant costs               $ 31,700 $ 32,200  
Compensation expense               $ 400 $ 600  
Percentage of special recognition bonus payment 70.00% 10.00%           20.00%    
Received for full settlement                   $ 4,300
Net operating losses     $ 238,000              
Unpaid salary             $ 500,000      
Plaintiffs seek damages value       $ 2,500            
Rent       $ 800            
InnoHold, LLC [Member]                    
Commitments and Contingencies [Line Items]                    
Plaintiffs seek damages value           $ 3,000        
Chief Executive Officer [Member]                    
Commitments and Contingencies [Line Items]                    
Cash payment         $ 5,000          
v3.25.1
Stockholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Jun. 27, 2024
Mar. 31, 2025
Mar. 12, 2025
Dec. 31, 2024
Jan. 23, 2024
Stockholders’ Equity [Line Items]          
Current NOL (in Dollars) $ 238        
Percentage of outstanding common stock 4.90% 50.00%      
Number of exchanging shares (in Shares)   1      
Number of shares.   1      
Exercise warrants percentage   49.90%      
Warrants To Lenders [Member]          
Stockholders’ Equity [Line Items]          
Warrants issued (in Shares)   20,000,000     20,000,000
Warrant [Member]          
Stockholders’ Equity [Line Items]          
Warrants issued (in Shares)     6,200,000    
Warrants exercisable price per share (in Dollars per share)   $ 0.01      
NOL Protective Charter Amendment [Member]          
Stockholders’ Equity [Line Items]          
Percentage of outstanding common stock 4.90%        
Preferred Stock [Member]          
Stockholders’ Equity [Line Items]          
Preferred stock authorized (in Shares)   5,000,000      
Minimum [Member]          
Stockholders’ Equity [Line Items]          
Trading days   20      
Maximum [Member]          
Stockholders’ Equity [Line Items]          
Trading days   30      
Class A common stock [Member]          
Stockholders’ Equity [Line Items]          
Common stock authorized (in Shares)   210,000,000   210,000,000  
Vote for each share   one      
Common stock, shares outstanding (in Shares)   107,955,000   107,545,000  
Price per share (in Dollars per share)   $ 0.0001   $ 0.0001 $ 0.01
Warrants exercisable price per share (in Dollars per share)   0.6979      
Class A common stock [Member] | Warrant [Member]          
Stockholders’ Equity [Line Items]          
Price per share (in Dollars per share)   24      
Class A common stock [Member] | Common Stock [Member]          
Stockholders’ Equity [Line Items]          
Warrants exercisable price per share (in Dollars per share)   $ 1.5      
Class B Common Stock [Member]          
Stockholders’ Equity [Line Items]          
Common stock authorized (in Shares)   90,000,000   90,000,000  
Common stock, shares outstanding (in Shares)   165,000   165,000  
Price per share (in Dollars per share)   $ 0.0001   $ 0.0001  
Class B Common Stock [Member] | Common Stock [Member]          
Stockholders’ Equity [Line Items]          
Common stock authorized (in Shares)   90,000,000      
Common stock, shares outstanding (in Shares)   200,000      
Series C Preferred Shares [Member]          
Stockholders’ Equity [Line Items]          
Preferred stock authorized (in Shares) 300,000        
Per share (in Dollars per share) $ 0.0001        
Purchase price per share (in Dollars per share)   $ 2.75      
NOL Rights Plan [Member]          
Stockholders’ Equity [Line Items]          
Percentage of outstanding common stock 4.90%        
NOL Rights Plan [Member] | Minimum [Member]          
Stockholders’ Equity [Line Items]          
Noncontrolling interest percentage 5.00%        
NOL Rights Plan [Member] | Maximum [Member]          
Stockholders’ Equity [Line Items]          
Noncontrolling interest percentage 50.00%        
Purple LLC [Member]          
Stockholders’ Equity [Line Items]          
Noncontrolling interest percentage   0.15%   0.15%  
v3.25.1
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Taxes [Line Items]    
Income (loss) before income taxes (in Dollars) $ 19.1 $ 50.2
State taxes (in Dollars)   $ 0.1
Effective tax rate (0.21%) (0.12%)
Statutory federal rate 21.00%  
Cash tax savings percentage 80.00%  
Estimated future cash tax, percentage 80.00%  
Unrecognized tax benefits (in Dollars) $ 1.1  
v3.25.1
Net Loss Per Common Share - Schedule of Basic and Diluted Weighted Average Shares Outstanding and Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Numerator:    
Net loss attributable to Purple Innovation, Inc. – basic $ (19,137) $ (50,217)
Less – net loss attributed to noncontrolling interest
Net loss attributable to Purple Innovation, Inc. – diluted $ (19,137) $ (50,217)
Denominator:    
Weighted average shares—basic 107,596,000 106,022,000
Add – dilutive effect of Class B shares
Weighted average shares—diluted 107,596,000 106,022,000
Net loss per common share:    
Basic $ (0.18) $ (0.47)
Diluted $ (0.18) $ (0.47)
v3.25.1
Net Loss Per Common Share - Schedule of Diluted Net Loss Per Common Share (Details) - shares
shares in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted net loss per common share 26,230 20,000
Restricted Stock Units (RSUs) [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted net loss per common share 3,397 3,693
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted net loss per common share 529 863
Class B Shares [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted net loss per common share 165 205
v3.25.1
Equity Compensation Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Equity Compensation Plans [Line Items]    
Weighted average grant date fair value per share (in Dollars per share)  
Restricted stock unit expense $ 368 $ 492
Employee Stock [Member]    
Equity Compensation Plans [Line Items]    
Remaining recognition period 1 month 6 days  
2017 Equity Incentive Plan [Member]    
Equity Compensation Plans [Line Items]    
Shares available for issuance (in Shares) 1.6  
Weighted average grant date fair value per share (in Dollars per share) $ 0.66  
2017 Equity Incentive Plan [Member] | Restricted Stock Units [Member]    
Equity Compensation Plans [Line Items]    
Restricted stock options granted (in Shares) 1.2  
Restricted stock unit expense $ 400 $ 500
Unrecognized stock compensation $ 2,800  
Unrecognized stock compensation period 1 year 9 months 18 days  
v3.25.1
Equity Compensation Plans - Schedule of Total Stock Option Activity (Details) - Stock Option [Member] - USD ($)
shares in Thousands
 3 Months Ended
Dec. 31, 2024
Mar. 31, 2025
Schedule of Total Stock Option Activity [Line Items]    
Options, outstanding Balance 529 529
Weighted Average Exercise Price, Options outstanding Balance $ 7.17 $ 7.17
Weighted Average Remaining Contractual Term in Years, Options outstanding Balance 2 years 2 months 12 days 1 year 10 months 24 days
Intrinsic Value, Options outstanding Balance
Options, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Remaining Contractual Term in Years, Granted  
Intrinsic Value, Granted  
Options, Expired  
Weighted Average Exercise Price, Expired  
Weighted Average Remaining Contractual Term in Years, Expired  
Intrinsic Value, Expired  
Options, Forfeited  
Weighted Average Exercise Price, Forfeited  
Weighted Average Remaining Contractual Term in Years, Forfeited  
Intrinsic Value, Forfeited  
v3.25.1
Equity Compensation Plans - Schedule of Outstanding and Exercisable Stock Options (Details)
shares in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
6.82 [Member]  
Schedule of Outstanding and Exercisable Stock Options [Line Items]  
Options Outstanding, Exercise Prices | $ / shares $ 6.82
Options Outstanding Number of Options Outstanding 500
Options Outstanding Weighted Average Remaining Life (Years) 2 years
Options Exercisable, Number of Options Exercisable 333
Options Exercisable, Weighted Average Remaining Life (Years) 2 years
Options Exercisable, Intrinsic Value | $
13.12 [Member]  
Schedule of Outstanding and Exercisable Stock Options [Line Items]  
Options Outstanding, Exercise Prices | $ / shares $ 13.12
Options Outstanding Number of Options Outstanding 29
Options Outstanding Weighted Average Remaining Life (Years) 1 month 6 days
Options Exercisable, Number of Options Exercisable 29
Options Exercisable, Weighted Average Remaining Life (Years) 1 month 6 days
Options Exercisable, Intrinsic Value | $
v3.25.1
Equity Compensation Plans - Schedule of Unvested Stock Option Activity (Details)
shares in Thousands
 3 Months Ended
Mar. 31, 2025
$ / shares
shares
Schedule of Unvested Stock Option Activity [Line Items]  
Options, Nonvested options beginning | shares 167
Weighted Average Grant Date Fair Value, Nonvested options beginning | $ / shares $ 0.22
Options, Granted | shares
Weighted Average Grant Date Fair Value, Granted | $ / shares
Options, Vested | shares
Weighted Average Grant Date Fair Value, Vested | $ / shares
Options, Forfeited | shares
Weighted Average Grant Date Fair Value, Forfeited | $ / shares
Options, Nonvested options ending | shares 167
Weighted Average Grant Date Fair Value, Nonvested options ending | $ / shares $ 0.22
v3.25.1
Equity Compensation Plans - Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Unit [Member]
shares in Thousands
 3 Months Ended
Mar. 31, 2025
$ / shares
shares
Schedule of Restricted Stock Unit Activity [Line Items]  
Options at beginning | shares 3,808
Weighted Average Grant Date Fair Value, Nonvested restricted stock units as of beginning | $ / shares $ 1.91
Options, Granted | shares 1,150
Weighted Average Grant Date Fair Value, Granted | $ / shares $ 0.66
Options, Vested | shares (897)
Weighted Average Grant Date Fair Value, Vested | $ / shares $ 2.16
Options, Forfeited | shares (664)
Weighted Average Grant Date Fair Value, Forfeited | $ / shares $ 2.26
Options at ending | shares 3,397
Weighted Average Grant Date Fair Value, Nonvested restricted stock units as of ending | $ / shares $ 1.35
v3.25.1
Equity Compensation Plans - Schedule of Non-Cash Stock Compensation Recognized in the Statement of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Non-Cash Stock Compensation and Statement of Operations [Line Items]    
Total non-cash stock-based compensation $ 368 $ 492
Cost of revenues [Member]    
Schedule of Non-Cash Stock Compensation and Statement of Operations [Line Items]    
Total non-cash stock-based compensation 103 87
Marketing and sales [Member]    
Schedule of Non-Cash Stock Compensation and Statement of Operations [Line Items]    
Total non-cash stock-based compensation (176) 96
General and administrative [Member]    
Schedule of Non-Cash Stock Compensation and Statement of Operations [Line Items]    
Total non-cash stock-based compensation 363 241
Research and development [Member]    
Schedule of Non-Cash Stock Compensation and Statement of Operations [Line Items]    
Total non-cash stock-based compensation $ 78 $ 68
v3.25.1
Employee Retirement Plan (Details) - Supplemental Employee Retirement Plan [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Employee Retirement Plan [Line Items]    
Employee contributions percentage 5.00%  
Contribution expense $ 1.1 $ 1.1
v3.25.1
Segment Information and Concentrations (Details)
 3 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2024
Segment Reporting [Line Items]    
Net revenues percentage 3.00%  
Insured by the federal deposit insurance corporation (in Dollars) $ 250,000  
Customers [Member]    
Segment Reporting [Line Items]    
Net revenues percentage 1.00% 0.00%
Customer Concentration Risk [Member] | Customer One [Member] | Accounts Receivable [Member]    
Segment Reporting [Line Items]    
Concentration risk percentage 36.00% 21.10%
Customer Concentration Risk [Member] | Customer One [Member] | Revenue Benchmark [Member]    
Segment Reporting [Line Items]    
Concentration risk percentage 11.90% 13.60%
Omni-Channel [Member]    
Segment Reporting [Line Items]    
Reportable segment 1  
E-Commerce Online Channels [Member]    
Segment Reporting [Line Items]    
Reportable segment 1  
v3.25.1
Segment Information and Concentrations - Schedule of Summarizes Segment Revenue, Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Summarizes Segment Revenue, Significant Segment Expenses [Line Items]    
Revenues, net $ 104,171 $ 120,033
Reductions (additions):    
Cost of revenues 63,125 78,313
Advertising expense 14,602 14,499
Marketing sales expense 7,187 8,399
Wholesale marketing and sales expense 4,323 6,164
Showrooms marketing and sales expense 10,514 12,400
General and administrative expense 14,487 19,728
Research and development expense 2,452 3,666
Restructuring, impairment and other related charges 1,960
Other segment items, net [1] 4,646 27,073
Income tax expense 41 59
Net loss attributable to noncontrolling interest (29) (51)
Net reductions 123,308 170,250
Segment net loss (19,137) (50,217)
Cost of revenues [Member]    
Reductions (additions):    
Cost of revenues 62,207 78,313
restructuring related charges [Member]    
Reductions (additions):    
Cost of revenues $ 918
[1] Other segment items, net include interest expense, other (income) expense, net, loss on extinguishment of debt, and change in fair value of warrant liabilities.
v3.25.1
Subsequent Events (Details) - USD ($)
 3 Months Ended
May 02, 2025
Mar. 12, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Subsequent Events [Line Items]          
Additional term loan   $ 20,000,000      
Initial principal amount from related party     $ 19,000,000 $ 61,000,000  
Repayment loan     $ 25,000,000  
Percentage of aggregate principal amount     2.50%    
Percentage of principal amount     100.00%    
Percentage of amendment fee     2.00%    
Additional warrants purchase     $ 21,414,000   $ 16,067,000
Second 2025 Amendment [Member]          
Subsequent Events [Line Items]          
Repayment loan     $ 61,000,000    
Percentage of aggregate principal amount     2.50%    
Percentage of amendment fee     0.25%    
Backstop fee     $ 150,000    
Warrant certain adjustment price (in Dollars per share)     $ 0.6979    
Subsequent Event [Member]          
Subsequent Events [Line Items]          
Additional term loan $ 20,000,000        
Initial principal amount from related party 20,000,000        
Class A Common Stock [Member]          
Subsequent Events [Line Items]          
Warrant certain adjustment price (in Dollars per share)     0.6979    
Warrant s strike price (in Dollars per share)     $ 1.5    
Class A Common Stock [Member] | SGI Warrants [Member]          
Subsequent Events [Line Items]          
Additional warrants purchase     $ 8,000,000    
Class A Common Stock [Member] | Second 2025 Amendment [Member]          
Subsequent Events [Line Items]          
Additional warrants purchase     $ 6,600,000    
Warrant certain adjustment price (in Dollars per share)     $ 1.5    
Minimum [Member]          
Subsequent Events [Line Items]          
Percentage of unpaid interest rate     0.10%    
Minimum [Member] | Subsequent Event [Member] | Second 2025 Amendment [Member]          
Subsequent Events [Line Items]          
Initial principal amount from related party 80,000,000        
Maximum [Member]          
Subsequent Events [Line Items]          
Percentage of unpaid interest rate     0.15%    
Maximum [Member] | Subsequent Event [Member] | Second 2025 Amendment [Member]          
Subsequent Events [Line Items]          
Initial principal amount from related party $ 100,000,000